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ABSTRACT OF DISSERTATION

ROLE OF CYCLOPHILIN D IN SECONDARY SPINAL CORD AND BRAIN
INJURY
In t he ho urs and day s following acu te C NS i njury, a se condary wave o f
events is initiated that exacerbate spinal tissue damage and neuronal cell death.
A pot ential m echanism dr iving t hese se condary ev ents is opening o f t he
mitochondrial per meability t ransition p ore ( mPTP) and su bsequent r elease of
several ce ll deat h proteins. P revious studies have sh own t hat i nhibition of
cyclophilin D (CypD), the ke y r egulating co mponent i n mPTP opening, w as
protective ag ainst i nsults that i nduce ne crotic cell deat h.
We therefore
hypothesized t hat CypD-null mice w ould sh ow i mproved functional an d
pathological out comes following sp inal co rd i njury ( SCI) and t raumatic brain
injury ( TBI). M oderate an d s evere sp inal co ntusion w as produced i n w ild-type
(WT) and CypD-null mice at t he T -10 l evel usi ng t he I nfinite H orizon i mpactor.
Changes in l ocomotor function w ere ev aluated using t he B asso Mouse Scale
(BMS) at 3 days post-injury followed by weekly testing for 4 weeks. H istological
assessment o f tissue sparing and l esion v olume w as performed 4 w eeks post
SCI. C alpain activity, measured by calpain-mediated spectrin degradation, was
assessed i n m oderate i njury onl y by western bl ot 2 4 h ours post S CI. R esults
showed t hat following m oderate S CI, CypD-null mice had no si gnificant
improvement in locomotor recovery or tissue sparing compared to wild-type mice.
Following se vere S CI, CypD-null mice sh owed si gnificantly l ower l ocomotor
recovery and decreased tissue sparing compared to WT mice. Calpain-mediated
spectrin deg radation was not si gnificantly r educed i n CypD-null mice co mpared
to WT mice 24h post moderate SCI. The lack of protective effects in CypD-null
mice suggests that more dominant mechanisms are involved in the pathology of
SCI. I n ad dition, C ypD m ay hav e a pr o su rvival r ole t hat i s dependent o n t he
severity of the spinal cord injury.
KEYWORDS: Spinal Cord Injury, Traumatic Brain Injury, Cyclophilin D,
Mitochondrial permeability, Calpain
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Chapter One
Primary and Secondary Pathology in Traumatic Spinal Cord and Brain
Injury
Introduction
Traumatic injury that disrupts essential neurological functions can severely
impact the quality of one’s life. Chronic sensory deregulation, cognitive
dysfunction, and motor impairment are just some of the debilitating
consequences of force induced neurological damage. Two of the most common
sources of neurological damage are traumatic injury to the spinal cord and the
brain. The pathology of these traumatic injuries can be categorized into two
major events. The first event is the primary injury, which is defined as the initial
mechanical damage upon the point of impact. The second event, called
secondary injury, occurs hours, days, and weeks following the primary injury.
During the time course of secondary injury, there is an acceleration of tissue
damage at the epicenter, or the point of injury, and at distal sites from the
epicenter. Defining these pathological events is critical when considering
therapeutic intervention following the injury. Unfortunately, there is little that can
be done to intervene with the damage suffered during the primary injury, as the
time course is too rapid for critical response. However, events during the
secondary injury present a window of opportunity to attenuate and prevent further
tissue damage. The ability for recovery from sensory and motor deficits following
traumatic brain and spinal cord injury can be greatly enhanced by therapeutic
intervention during the course of secondary injury. Thus, there is a dire need for
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research into the physiological and biological mechanisms that drive secondary
injury cascades. Uncovering the function of key pathways in secondary
pathology can serve as the foundation for clinical treatment and recovery for
those suffering from traumatic spinal cord and brain injury.

Pathology of Traumatic Spinal Cord Injury
Each year, approximately 7800 people suffer from a traumatic injury to the
spinal cord in the United States (NSCISC 2009). Though these injuries can
occur in any age group, it is most prevalent at the ages of 16 to 30 years. Of
these documented cases each, motor vehicle accidents are the leading cause of
spinal cord injury. Other incidents, such as common falls, acts of violence, and
sports related injuries, all contribute to spinal cord injury (Figure 1). The most
common cause of spinal cord injury occurs from a compression and flexion of
both the cervical and thoracic vertebra resulting in a fracturing or dislocation of
the vertebral column (NSCISC 2009).
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Causes of Spinal Cord Injury
Other
2%

Sports
8%

Falls
22%

Motor
44%
Violence
24%

Figure 1.1 Causes of spinal cord injury in the U.S. The leading cause of SCI
is motor accident at 44%. Violent assaults are next at 24% with injurious falls at
22%. Sports related accidents and others makeup 8% and 2% of causes of SCI.
Chart modified from 2009 statistical data obtained from The National Spinal Cord
Injury Association.
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The impairments that follow spinal cord injuries stem from damaged axons
and subsequently disruption of neurotransmission up and down the spinal cord.
Perhaps the most notable deficit following spinal injury is loss of mobility from
impaired neurotransmission to skeletal muscles. There is also significant
impairment in autonomic functions as evident by chronic sensation of pain and
bowel and bladder dysfunction. However, the severity of the spinal injury is often
indicated by the extent of respiratory complications. Significant damage to the
diaphragm and respiratory pathway indicates a high vertebral level injury. Spinal
injuries that occur higher on the vertebral column, specifically at the cervical
level, result in full or partial tetraplegia. Damage as high as the C3 level will
produce complete loss of motor and sensory function from the neck down with
the requirement of a ventilator for breathing. Injuries occurring at lower levels in
the vertebral column, such as the thoracic level, result in paraplegia. One may
still have control over head, neck, and arm function, but may suffer complete loss
of lower limb mobility and autonomic control.
The degree of functional loss following spinal cord injuries is often
classified as complete or incomplete injuries. Individuals diagnosed as
incomplete, reported as approximately 45% of all U.S. cases, will still maintain a
degree of neurological activity below the site of injury. Thus, motor and sensory
function may be retained at some level, allowing for a greater recovery. Those
diagnosed with complete spinal injury, reported as approximately 55% of U.S.
cases, will have a complete loss of sensory and motor function below the site of
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injury, often accompanied by chronic autonomic irregularities (Figure 1.2)
(NSCISC 2009).

Injury Classification

Complete
45%

Incomplete
55%

Complete loss
of motor and
sensory
function

Some motor
and sensory
Function

Figure 1.2 Classification of spinal cord injuries since 1988. 55% of reported SCI
cases in the U.S. result in incomplete paralysis. 45% of reported cases result in
complete paralysis. Chart is modified from the 2009 statistical data obtained from
The National Spinal Cord Injury Association.
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Primary spinal cord damage occurs from the mechanical forces upon
initial impact that cause spinal tissue to abruptly shift, shearing neuronal and
endothelial cell membranes (Tator and Fehlings 1991; Profyris, Cheema et al.
2004). The shifting of tissue caudal and rostral to the epicenter, or the impact
zone, places the greatest stress at the center of the cord (Blight et al. 1986;
Mautes et al. 2000). This creates a unique phenomenon where vessels and
axons localized near the surface of the cord experience little trauma. However,
the enriched microvascular environment of the central gray matter and the axons
located close to the gray matter experience severe stretching and shearing
(Blight et al. 1986; Mautes et al. 2000; Young 2002).
The central hemorrhage following damage encompasses the gray area of
the epicenter and radiates into the surrounding white matter (Noble et al. 1989;
Noble et al. 1996; Mautes et al. 2000). Regions extending in the caudal and
rostral direction from the epicenter show hemorrhagic lesion localized primarily to
the dorsal columns (Mautes et al. 2000). Despite the initial formation of a
hemorrhagic lesion, there is very little gross damage to the spinal cord.
However, during the secondary wave of injury, the hemorrhaging that occurred
during the initial injury triggers a wave of further necrosis and apoptosis causing
massive tissue degeneration and cellular death at and below the sight of injury
(Tator et al. 1991).
In the first few hours of the secondary wave, tissue surrounding the
primary lesion site appears pale due to edema response to injury. This
surrounding tissue undergoes necrosis, further expanding the lesion site evolving
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into a cyst cavitations bordered by glial scar tissue (Guth et al. 1999; Beattie et
al. 2002). By the eighth week, the spinal lesion has localized to the dorsal
columns (Guth et al. 1999; Basso et al. 2002). The cystic lesion has now
extended caudal and rostral to the epicenter (Profyris et al. 2004). At the lesion
site, there is a persistent neutrophil infiltration and glial response that prevents
any arborization of blood vessels. However, this event in the dorsal columns
attenuates over the period of a week. Macrophage presence gradually
disappears by eight weeks and any cyst-like cavitation has receded to the rim of
the lesion, allowing dense innervations of blood vessels and regenerated nerve
fibers into the dorsal columns (Guth et al. 1999).
The histopathological changes observed in the dorsal columns may stem
from Wallerian degeneration of axons around the site of injury (Dusart and
Schwab 1994; Guth, Zhang et al. 1999). Following spinal trauma, axonal
swelling and myelin rupturing continue for approximately 24 hours, expelling
axonal debris into the extracellular space (Profyris et al. 2004). Accumulation of
organelles in axonal bulb has been documented, possibly due to disruption and
blockage of axoplasma flow (Anthes et al. 1995). Rupturing of axonal
membranes and leakage of organelles leads to a low intra-axonal volume. This
low volume allows myelin to collapse upon itself resulting in axonal invagination
(Balentine 1988; Anthes et al. 1995). Tissue compression, red blood cell
damage, and blood-brain-barrier breakdown within the spinal tissue creates an
ischemic environment that is conducive to cell death (Mautes et al. 2000).
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These waves of necrotic to apoptotic cascades proceed in a unique
pathological track away from the site of injury. White matter, extending caudal
from the impact site, becomes the primary target for apoptosis (Crowe et al.
1997). Apoptotic death not only effects neurons, but non neuronal cells,
specifically oligodendrocytes, become a prime targets in the late stages of
delayed death (David 2002; Profyris, Cheema et al. 2004). The loss of
oligodendrocytes deprives neurons of trophic support resulting in impaired
mylenation of injured axons. Another devastating consequence of
oligodendrocyte death is the loss of spared, healthy axons around the injury site
and in remote areas (Blight et al. 1986; Crowe et al. 1997). Subsequently, both
ascending and descending axons undergo Wallerian degeneration of axons, a
process in which axonal cytoskeleton disintegrates and disruption of the axonal
membrane (David 2002; Profyris et al. 2004).

Pathology of Traumatic Brain Injury
In the United States of America, there is an estimated 1.5 million head
injuries each year (braintrauma.org, CDC 2007). Traumatic brain injury is the
leading cause of death in children and adults with approximately 52,000 deaths is
the result from a sudden trauma to the head (Rutland-Brown et al. 2006;
Prevention 2007). Some of the most common causes of head trauma are falls,
motor crashes, and sports injuries (Figure 2) (Langlois et al. 2006; Prevention
2007). In addition, traumatic brain injuries have become a critical concern
amongst active duty soldiers serving in war zones. It was reported by Veteran’s
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advocates that an estimated 10 to 20% of Iraqi veterans display some gradient of
brain injury (Prevention 2007).

Causes of Traumatic Brain Injury
Assault
14%

Falls
36%

Blunt Strike
24%
Motor
26%

Figure 2 Causes of Traumatic Brain Injury in the United States. Approximately
36% of all TBI cases in the U.S. result from common falls. Motor accidents make
up 26% of all reported TBI cases. Blunt strikes to the head make up 24% of all
TBI ca ses while 14% o f all TBI ca ses r esult from v iolent assaults. G raph
modified from 2007 statistical data collected by the The CDC National Center for
Injury Prevention and Control.
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The forces that damage the brain can range from a focal contusion,
directional acceleration and deceleration of the cranium, or blast-induced
concussions. Focal contusion based injuries are the result of a blunt force directly
to the cranium. With focal contusion, there may be a fracturing of the skull,
tissue deformation, vascular disruption and subsequent hemorrhaging (Gaetz
2004). However, a direct force to the head is not necessary for producing TBI.
The sheering forces from violent head movement throughout space can produce
severe brain injury (Ommaya et al. 1974; Varney et al. 1995; Gieron et al. 1998).
Forceful motion of the head in a rotational or forward and backward motion
induces a sheering of blood vessels and neuronal components (Ommaya et al.
1974; Gaetz 2004). The initial impact produces an injury gradient with damages
seen at cortical levels and, depending on severity, spreading throughout
subcortical areas (Pettus et al. 1994; Gaetz 2004). Severe blasts, such as that
induced by high powered weapons or explosives, produces dramatic pressure
changes causing rupturing and shearing of organs with tertiary damage caused
by propagation of the blast wave throughout the body (Mayorga 1997; Elder and
Cristian 2009).
The observable symptoms of any trauma to the head range from mild to
severe. Mild symptoms include headache, confusion, fatigue, and blurred vision.
More sever symptoms includes convulsions, numbness in the extremities and
loss of consciousness. The focus of this chapter will emphasize focal contusion
pathology, as the model used for experimentation is contusion-induced brain
deformation.
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A pathological hallmark in acute brain contusion is vascular damage from
deformation of the skull (Davis 2000). Hemorrhagic lesions following contusion
are classified as extradural and intradural hematomas (Davis 2000). Extradural
hematomas are caused by the fracturing of the skull with subsequent shearing of
dural matter directly beneath the skull along with the vasculature network (Davis
2000). Intradural hematomas can occur without fracturing of the skull and are
typically induced by the acceleration and deceleration of the brain from
contusions and are more indicative of secondary or delayed damage (Davis
2000). Occlusion of subdural veins from dramatic shifting forces is a hallmark of
an intradural injury called subdural hematoma. Another form of intradural injury
is intracerebral hemaetoma, characterized as a collective swelling or clotting from
extending into white matter, corpus callosum, and basal ganglia (Davis 2000).
Auto regulation of cerebrovascular flow is critical for vascular dilation and
constriction in response to cranial pressure (Werner et al. 2007). Primary
mechanical damage often leads to impaired auto regulation of cerebrovascular
flow, creating an ischemic like environment (Hermanns et al. 2001).
Vascular damage is the primary pathological outcome seen in the initial
stages of brain injury. The ischemic environment created by the initial vascular
damage triggers further waves of deleterious events. Peripheral damage may be
initiated from peri-infarct depolarization, a global depolarization phenomenon
occurring in both neuronal and glial cells in the penumbra (Nedergaard 1988;
Church and Andrew 2005). Cortical spreading depression (CSD), though typically
not involved in tissue damage, may actually contribute to additional cell loss
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following contusion as observed in recent electrophysiological studies (Church
and Andrew 2005; Fabricius, Fuhr et al. 2006; Hartings, Gugliotta et al. 2008).
In TBI, secondary neurodegeneration has been reported in several areas
adjacent to and quite distal from the impact site following experimental brain
injury (Hall et al. 2005; Hall et al. 2008). Depending on the severity of injury,
tissue damage may be observed in sub regions of the hippocampal formation,
the thalamus, and dorsal regions of the striatum over a 48 hour period (Dixon,
Kochanek et al. 1999; Hall, Sullivan et al. 2005; Hall, Bryant et al. 2008).
Extensive axonal damage has also been documented in sub regions of the
hippocampus, the internal capsule, thalamic nuclei, and as distal as regions in
the cerebellum and brain stem (Lighthall et al. 1990; Hall et al. 2005). These
observations were reported at later times, from 24 hours to 7 days, following
cortical contusion suggesting a diffuse mechanism of axonal degeneration that is
characteristic of secondary pathology (Lighthall, Goshgarian et al. 1990; Hall,
Sullivan et al. 2005). Mechanisms contributing to these secondary events will be
discussed in greater detail below.
Following TBI, the ischemic environment from vascular damage gives way
to the secondary cascade of cellular damage triggered by abnormal levels of
extracellular glutamate (Arundine and bTymianski 2004; Gaetz 2004). As
discussed earlier, massive depolarization and subsequent Ca2+ homeostasis
disruption propagate a cycle of secondary cell death (Choi 1988; Fiskum
2000; White, Sullivan et al. 2000; Arundine and Tymianski 2004; Gaetz 2004).
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Cell Death in Traumatic Spinal Cord and Brain Injury
This introduction has so far discussed much of the vascular damage from
primary injury and the spatial and temporal characteristics of tissue damage from
secondary damage. A more detailed discussion of the cellular events effected
and contributing to secondary damage is critical as it emphasizes key
mechanism targeted by current therapeutic drugs. Though, both necrotic and
apoptotic events are apparent during secondary damage, the distinction is more
complex than often reported as both events can occur in parallel within the same
cell (Gaetz 2004).
The history of excitotoxicity by various excitatory amino acids has long
been established as detrimental force in neuronal death. Glutamate, specifically,
has shown to be intensely involved in acute and delayed neurological trauma
(Olney 1971; Choi 1988; Goldberg, Monyer et al. 1988; Panter, Yum et al. 1990;
Arundine and Tymianski 2004). Massive depolarization, often in response to the
ischemic environment induced from primary damage, triggers further neuronal
glutamate release, leakage of intracellular glutamate, and dysfunctional
glutamate uptake (Mills, Fullwood et al. 2001; Arundine and Tymianski 2004;
Gaetz 2004). Collectively, these events propagate a detrimental loop of
glutamate release and autocrine-like stimulation of the same cell. Furthermore,
abnormal levels of extracellular glutamate stimulate and release inhibition of
glutamate-specific channels, specifically N-methyl-D -aspartate (NMDA), αamino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (Kwong et al.) and kainite
(Doble 1999; Profyris, Cheema et al. 2004). What follows is further disruption in
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ionic balance by large influxes of Na into the cell (Doble 1999; Profyris, Cheema
et al. 2004) . The cell is now subjected to increased water influx and the fatal
occurrence of cell lysis (Doble 1999; Profyris, Cheema et al. 2004). It is a
collective effort of ion imbalance that triggers disruption of a cell’s intrinsic
machinery. However, elevated Ca2+ in both the extracellular and intracellular
environment has historically been the subject of intense research in the field of
brain and spinal trauma (Maynard et al. 1977; Happel et al. 1981; Banik et al.
1984; Seliger et al. 1989; Gelderd et al. 1990; Moriya et al. 1994; Kampfl et al.
1996; Rzigalinski et al. 1998; Weber et al. 1999; Bondarenko et al. 2001; Farkas
et al. 2005; Nehrt et al. 2007).
The massive depolarization observed in secondary injury is accompanied
by large influxes of Ca2+ through voltage gated Ca2+ channels (Profyris et al.
2004). Inside the cell, increasing Ca2+ concentrations actually mobilizes
intracellular stores of Ca2+ that activate several deleterious Ca2+ dependent
enzymes and disrupt mitochondrial function (Banik, Hogan et al. 1982; Moriya,
Hassan et al. 1994; Doble 1999; Sullivan, Krishnamurthy et al. 2007). Perhaps
the seminal event in death of neurons and non neuronal cells during secondary
neurological injury is Ca2+ induced permeability of the mitochondria. The
following section will address the role of mitochondria in cell vitality and how the
influx of Ca2+ following injury can compromise mitochondria function.

14

Mitochondrial Dysfunction in Traumatic Spinal Cord and Brain Injury
Survival and development of all cells is largely dependent on the
bioenergetics of the mitochondria. These powerhouse structures are critical in
the metabolism of energy sources and feature apoptotic pathways involved in
development and cellular trauma (Fiskum 2000; Wieloch 2001; Sullivan,
Rabchevsky et al. 2005). Much of neuronal activity, such as the demanding
plasma ion pumps, is almost exclusively dependent on adenosine triphosphate
(ATP). Tissue stores and anaerobic glycolysis only provide brief supplies ATP.
However, the mitochondria, through breakdown of its dominant substrate
pyruvate, is able to generate a rapid and abundant supply of ATP and ATP
turnover is the mediating factor in mitochondrial respiration(Budd and Nicholls
1998; Nicholls and Ward 2000). Mitochondria are also critical to neuronal
function due to their ability to sequester calcium ions, a function critical during
neuronal hyperactivity (Ichas and Mazat 1998; Rizzuto, Pinton et al. 1999;
Nicholls and Ward 2000). Under physiological conditions, transport of Ca2+ into
the mitochondria is dependent on the presence of an electrogenic transporter,
the Ca2+ uniporter, as opposed to dependence on ATP hydrolysis (Ichas and
Mazat 1998; Rizzuto, Pinton et al. 1999; Bano, Young et al. 2005). The Ca2+
uniporter facilitates ion diffusion in the direction of its electrochemical gradient.
This calcium release is facilitated by exchange with the Na+/ Ca2+ antiporter.
Together with the Na+/H+ antiporter, a slow, continuous cycling of Ca2+ across the
mitochondrial inner membrane is established (Crompton et al. 1998; Crompton
1999; Sullivan et al. 2005). Increases in cytosolic Ca2+ can trigger further release
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of Ca2+ from neuronal intracellular compartment known as the smooth
endoplasmic reticulum. Ryanodine receptors, located on smooth endoplasmic
reticulum, and the second messenger metabolite innositoltriphosphate3 are
sensitive to intracellular calcium levels and respond by releasing stored calcium
(Bardo et al. 2006). This excessive rise in intracellular Ca2+ can compromise
mitochondrial function (Nicholls 1978; Crompton 1999). Pathological conditions
can facilitate large increases in extracellular Ca2+, ultimately leading to
mitochondrial matrix Ca2+ overload and subsequent increased mitochondrial
permeability (mPT) (Hunter, Haworth et al. 1976; Hunter and Haworth 1979;
Szabo and Zoratti 1992; Bernardi and Petronilli 1996).

Mitochondrial Permeability Transitional Pore
Mitochondrial permeability (mPT) is defined as a rapid increase in the
permeability of the inner mitochondrial membrane space to solutes with
molecular masses less than 1500 Daltons (Hunter and Haworth 1979; Nicolli,
Basso et al. 1996; Sullivan, Rabchevsky et al. 2005). Increased permeability of
the mitochondria results in a swelling phenomenon. Crompton and colleagues
attributed this swelling to a high concentration of protein debris left in the inner
membrane following passage of solutes (Crompton 1999; Halestrap, McStay et
al. 2002). Early studies hypothesized that mitochondrial invertebrate
permeability was another means of Ca2+ transport, specifically an ionic efflux
mechanism (Gunter et al. 1990). However, extensive studies revealed this not to
be the case as the increased permeability was due to the formation of a
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nonselective megachannel (Bernardi and Petronilli 1996; Sullivan, Rabchevsky et
al. 2005). Furthermore, unregulated opening of this megachannel, termed the
mitochondrial permeability transition pore (mPTP), was found to be a driving
mechanism behind apoptotic and necrotic cell death (Szabo and Zoratti 1991;
Szabo and Zoratti 1992; Crompton 1999; Shimizu, Narita et al. 1999; Fiskum
2000). Formation and opening of the mPTP trigger a series of detrimental events
that ultimately disrupt mitochondria bioenergetics (Figure 2). This is a
pathological hallmark of necrotic cell death, such as that observed under periods
of ischemia/reperfusion (Kerr, Suleiman et al. 1999; Kim, He et al. 2003; Leung,
Varanyuwatana et al. 2008).
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Figure 3 Simplified illustration of mPTP complex. CypD binds to the ANT/VDAC
complex initiating mPTP formation and release ofµ-calpain, AIF, and EndoG. CsA
inhibits CypD binding and subsequent mPTP formation. Diagram courtesy of Dr.
James Geddes.
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Swelling of the mitochondrial IMM and subsequent membrane
permeability results in decay of the inner membrane potential and subsequent
uncoupling of the electron transport system. Dramatic increases in Ca2+
concentrations give rise to reactive oxygen species (ROS), exposing the electron
transport chain to free radicals that disrupt oxidative phosporylation. This
breakdown of oxidative phosphorylation actually leads to hydrolyses of ATP by
reversal of ATPase, the enzymatic machinery responsible for translocating
protons across the inter-membrane (Szabo, Bernardi et al. 1992; Zoratti and
Szabo 1995; Halestrap, Clarke et al. 2004; Forte, Gold et al. 2007). Ultimately,
there is a decrease in ATP production as a result of adenine nucleotide depletion
along with increased phosphate, and subsequently pH (Fiskum 2000; Halestrap,
Clarke et al. 2004). These events sensitize the opening of the mPTP which
mediates further cell damage by release of several degrading enzymes (Ding,
Shen et al. 2002; Ferrand-Drake, Zhu et al. 2003; Kim, He et al. 2003).
mPTP formation and opening has also been implicated in apoptosis.
Recent reports have suggested that mPTP can transition from necrotic induced
cell death to a mediator of apoptotic pathways (Kim, He et al. 2003; Kim, He et
al. 2003). Apoptotic stimuli, such as members of the pro apoptotic family of Bcl-2
stimulate opening of the mPTP (Crompton 1999; Kroemer and Reed 2000;
Halestrap, McStay et al. 2002). The increased permeability of the mitochondrial
outer membrane permits release of such apoptotic factors as cytochrome C,
apoptosis inducing factor (AIF), and Smac/Diablo from the mitochondrial inter-
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membrane (Crompton 1999; Annis, Zamzami et al. 2001; Halestrap, McStay et
al. 2002).
The emerging role of mPTP in pathological events produced an intensive
search for the components that constitute the megachannel. The three best
characterized components to date are the adenine nucleotide translocase, the
voltage dependent anion channel, and cyclophilin D. Though recent reports have
uncovered a more complex makeup of the mPTP than originally documented, the
following section will review the three basic components mentioned above.

The adenine nucleotide translocase (ANT) is a 30 kDA protein located
exclusively to the inner membrane of the mitochondria (Brustovetsky and
Klingenberg 1996; Crompton, Virji et al. 1998; Vieira, Haouzi et al. 2000). The
ANT exhibits many operations characteristic of the mPTP. Upon exposure to
high concentrations of Ca2+, the ANT undergoes a conformational change from a
selective antiporter to a nonselective pore (Brustovetsky and Klingenberg 1996;
Crompton 1999). (Crompton, Virji et al. 1998; Crompton 1999). (Al-Nasser et al.
1986). The normal role of the ANT is the translocation of adenine nucleotides,
specifically, ATP and ADP across the inner mitocondrial membrane, which
serves as a proton-driven co-transport. This translocation of ATP and ADP allow
for charge compensation to the calcium mediated increase in matrix volume, an
effect by K+ and subsequent water entry (Haworth and Hunter 1980; Halestrap,
McStay et al. 2002). Nucleotides that interact with ANT are limited to only ADP,
dADP, and ATP and when bound in the c-sate, induce an active channel
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conformation (Woodfield, Ruck et al. 1998). Recently, it has been documented
that a range of pro-apoptotic proteins are able to bind to ANT, including Bcl-2 and
Bax (Marzo, Brenner et al. 1998). Previously research has shown that Bax
binding cooperates in mPTP opening (Marzo, Brenner et al. 1998; Kowaltowski
2000). In addition, cells over expressing Bcl-2 allowed for greater mitochondrial
Ca2+ capacity, attenuation in mitochondrial membrane potential, and generation
of a higher reduction state, opposing the increases oxidative state induced by
mPTP opening (Murphy, Bredesen et al. 1996; Vieira, Haouzi et al. 2000). While
these characteristics demonstrate that ANTs are crucial in mPTP formation,
recent literature has demonstrated that mPTP is still functional in ANT knock out
models (Kokoszka et al. 2004). Thus, other components forming the mPTP were
investigated to determine those critical in pore regulation.

Voltage Dependent Anion Channel (VDAC). The release of apoptogenic factors,
such as cytocrome C and AIF, from mitochondria demonstrate increased
permeability of the outer membrane (Priault, Camougrand et al. 1999; Tsujimoto
and Shimizu 2000). It is now widely accepted that pro-apoptotic members of the
Bcl-2 family can directly control mitochondrial permeability during apoptosis
(Priault, Chaudhuri et al. 1999; Shimizu, Narita et al. 1999; Tsujimoto and
Shimizu 2000). Further investigations showed a highly conserved barrel protein
spanning the outer membrane, the voltage dependent anion channel (VDAC),
that serves as a mitochondrial highway for all entering and exiting metabolites
(Lemasters et al. 2006). The channel is voltage dependent in that both positive
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and negative potentials close the channel. VDAC also demonstrates ion
selectivity when in an open conformation (Colombini 1983; Lemasters and
Holmuhamedov 2006).
Open conformation of the VDAC is critical for release and uptake of
respiratory substrates, specifically ATP and ADP that facilitate mitochondrial
function (Vander Heiden, Li et al. 2001). As discussed earlier, interaction of
proapoptotic factors with VDAC facilitates mitochondrial dysfunction. Recent
reports revealed that interaction of pro-apoptotic Bcl members close VDAC,
prohibiting mitochondrial respiration (Vander Heiden, Li et al. 2001). VDAC
closure leads to increased outer membrane permeability and translocation of
cytochrome c (Rostovtseva, Antonsson et al. 2004). These events can occur
either independently or collectively with mitochondrial inner membrane
permeability and subsequent collapse of membrane potential (Priault,
Camougrand et al. 1999; Tsujimoto and Shimizu 2000). Though several reports
have implicated VDAC in apoptotic induced mitochondrial dysfunction, there is
still uncertainty in its involvement in mPTP formation. Similar to ANT, knock-out
models of VDAC did not affect mPTP formation and VDAC closure does not
attenuate Ca2+ flux (Basso, Fante et al. 2005; Rostovtseva, Tan et al. 2005).
Further investigations into a mediating component of the mPTP unveiled a
potential candidate from cyclophilin family called cyclophilin D (cypD).

Cyclophilin D. It was discovered that opening of the mPTP could be inhibited
specifically by sub-micro molar concentrations of the immunosuppressive drug,
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cyclosporin A (CsA)(Crompton, Ellinger et al. 1988; Nicolli, Basso et al. 1996;
Kowaltowski, Smaili et al. 2000). Specifically, these early studies revealed that
CsA inhibited the activities of peptidyl-prolyl-cis-trans-isomerase (PPIase) located
in the mitochondria matrix (Crompton et al. 1988). This PPIase was identified as
CypD (Crompton et al. 1988).
Cyclophilins display catalytic properties by refolding denatured proteins
and importing the reconformed proteins into organelles, as evident by a retarded
rate of protein folding in cyclophilin mutant yeast mitochondria (Lin, Hasumi et al.
1988; Lithgow, Horst et al. 1995; Matouschek, Rospert et al. 1995). In addition,
cyclophilins are recruited to fully functional protein complexes (Wu, Matunis et al.
1995; Crompton, Virji et al. 1998; Jaschke, Mi et al. 1998). Several reports
showed that CypD binds to the ANT/VDAC complex, confirming CypD as a
component for mPTP configuration (Crompton, Virji et al. 1998; Woodfield, Ruck
et al. 1998; Halestrap, McStay et al. 2002; Leung and Halestrap 2008; Leung,
Varanyuwatana et al. 2008). Evidence points to CypD’s catalytic properties as a
potential mechanism for proper folding of pore component aggregates, resulting
in mPTP formation (Connern and Halestrap 1994; Connern and Halestrap 1996;
Leung, Varanyuwatana et al. 2008). It is important to note that new research
suggest that another pore component consisting of a phosphate carrier, PiC, is
the primary target of CypD induced conformational change as opposed to ANT
(Leung et al. 2008). This demonstrates the ever emerging complexity of the
mPTP.
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Both pharmaceutical inhibition of CypD and knock out of the CypD gene
Ppif have shown modest protection in animal models of neurotrauma. CsA and
its analog NIM811 showed modest improvement in tissue and behavioral
assessment following traumatic brain injury and spinal cord injury (Sullivan,
Rabchevsky et al. 2000; McEwen, Sullivan et al. 2007; Ravikumar, McEwen et al.
2007; Mbye, Singh et al. 2008). Other pathological states, such as muscle
dennervation, multiple sclerosis, and oxidative induced hippocampal damage, all
illustrated the role of CypD as a potent mediator of cell damage (Khaspekov,
Friberg et al. 1999; Csukly, Ascah et al. 2006; Forte, Gold et al. 2007). However,
the protective effects produced from CypD inhibition are not universal to all
deleterious pathways. Several reports have shown that the efficacy of targeting
CypD may only be protective under necrotic events. Cell death induced by
reactive oxygen species or Ca2+ overload, such as that observed in ischemic
conditions, was attenuated by CypD ablation (Baines, Kaiser et al. 2005;
Nakagawa, Shimizu et al. 2005; Schneider 2005). Apoptotic stimuli, such as
members of the Bcl-2 family, induce cell death regardless of CypD inhibition
(Baines, Kaiser et al. 2005; Basso, Fante et al. 2005; Nakagawa, Shimizu et al.
2005).

Calpain and Traumatic Spinal Cord and Brain Injury
The disruption of Ca2+ homeostasis and subsequent mitochondrial
function can unleash a host of enzymatic activity that further mediates cell
damage. MPTP opening is a driving force behind necrotic death, however,
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closure of this channel may only divert the necrotic pathway to apoptosis
(Nicotera and Leist 1997; Halestrap, McStay et al. 2002). Increased
permeability of the outer membrane allow leakage of inner membrane factors
such as apoptosis inducing factor (AIF), cytochrome c, and Smac/Diablo
(Kroemer and Reed 2000; Loeffler, Daugas et al. 2001; Halestrap, McStay et al.
2002; Ferrand-Drake, Zhu et al. 2003). Additionally, members of the cysteine
protease family are also activated and mobilized. Caspases mediate apoptosis
by disruption of DNA repair, mRNA splicing, and cytoskeletal breakdown and
reorganization (Kermer, Klocker et al. 1999; Kermer, Klocker et al. 1999). Other
members of the cysteine protease family are Ca2+ activated proteolytic enzymes
called calpains. The following section will discuss in greater detail the structure
and physiological functions of calpains.
To date, approximately 15 calpain isoforms have been identified in
humans. The typical calpains are ubiquitously expressed while atypical calpains
are tissue specific (Goll et al. 2003). Many of these isoforms have prominent
roles in such pathological conditions as diabetes, muscular dystrophy, and brain
and spinal injury (Banik, Shields et al. 1998; Huang and Wang 2001; Zatz and
Starling 2005; Deng, Thompson et al. 2007; Liu, Liu et al. 2008). Two of the
most extensively characterized isoforms are the typical calpainsµ-calpain and mcalpain. The classifications are based on their large catalytic subunits calpain 1
and calpain 2 (Goll et al. 2003; Bevers et al. 2007). In addition to their distinct
catalytic subunits, these two isoforms share a common regulatory small subunit
(Cong et al. 1989; Bevers et al. 2007). Both isoforms are regarded as cytosolic
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enzymes, though recentlyµ- calpain was found to be expressed in the
mitochondria inner membrane (Badugu et al. 2007). One of the distinguishing
characteristics amongstµ-calpain and m-calpain is the concentrations of Ca2+
required for activation (Goll et al. 2003). For example, m-calpain requires
approximately 1 to 20um concentration whereas 250 to 750um concentration of
Ca2+ are required forµ-calpain (Zimmerman et al. 1984; Goll et al. 2003; Li et al.
2004).
Several proteins are substrates for calpains such as cytoskeletal
structural proteins, cell motility proteins, and calcium dependent enzymes
(Posmantur et al. 1994; Pang et al. 1996; Azam et al. 2001). Bothµ-and m-calpain
undergo autolysis in the presence of Ca2+ (Cong, Goll et al. 1989; Edmunds,
Nagainis et al. 1991; Saido, Nagao et al. 1992). SDS-PAGE revealed that
autolysis of both calpain isoforms resulted in a reduced mass of the 80 kDa
subunit to 76 kDa and the 28 kDa subunit to 18 kDa (Graham-Siegenthaler et al.
1994). As a result of calpain autolysis, specifically the large subunit, the Ca2+
concentration for half-maximal proteolytic activity is reduced with no
consequential affect of enzyme specificity (Edmunds, Nagainis et al. 1991; Goll,
Thompson et al. 2003; Li, Thompson et al. 2004). Calpains can function under a
controlled state during normal physiological events. Calpain targets several
substrates for enzymatic degradation such as cytoskeletal structural proteins, cell
motility proteins, and other calcium dependent enzymes. For example, calpain
mediated degradation of spectrin, a cytoskeleton protein, allows for synaptic
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remodeling, a critical function in long term synaptic potentiation and memory
storage (Luscher et al. 2000; Liu et al. 2008).
Calpain can be endogenously regulated by Calpastatin (Emori et al. 1987;
Murachi 1989; Wendt et al. 2004). Calpastatin has multiple inhibitory domains
and is capable of binding to several molecules of calpain in a Ca2+ dependent
manner. (Wendt et al. 2004). The Ca2+ requirement for endogenous inhibition is
less than that for calpain activation (Kapprell et al. 1989; Wendt et al. 2004).
However, under pathological conditions, calpastatin inhibition is reversible and
can lead to unregulated activation of calpain (Arrigoni et al. 1991; Springer et al.
1997; Tidball et al. 2002; Crocker et al. 2003; Bevers et al. 2007).
The dramatic increase in Ca2+ due to excitotoxic events may lead to a
sustained activation of calpain. Neuronal cell bodies and dendrites consist of a
vast network of microtubules, which maintain morphological stability. One of the
critical proteins that constitute the microtubule structure is microtubuleassociated protein (MAP-2). MAP-2 is highly susceptible to calpain degradation
(Saatman et al. 1998; Goll et al. 2003; Liu et al. 2008). Post synaptic bulbs and
axonal components are also vulnerable to calpain degradation. Alpha-II spectrin
and neurofilaments (NF) are enriched in the axonal and post synapse
cytoskeleton. Both of these proteins are also substrates of calpain (Dutta et al.
2002; Goll et al. 2003). Further perpetuating the detrimental cycle of excitoxicity
is calpain’s targeting of glutamate receptors. Cleavage and subsequent
truncation of several of the ionotropic receptors allows for further uncontested Ca
entry into the cell (Minger et al. 1998; Simpkins et al. 2003).
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Elevated calpain activity has been well documented as major contributor
to secondary tissue damage in both spinal cord and brain injury. In spinal cord
injury, early research, especially that of Banik and colleagues showed that
calpain activity induces much of the structural damage in cell bodies and axons
following spinal injury (Banik et al. 1998). These studies demonstrated that a
calcium activated proteinase contributed to early losses in neurofilament proteins
followed by granular axonal degeneration and myelin loss at later time points
following spinal cord lesion (Banik, Hogan et al. 1982; Banik, Hogan et al. 1984;
Banik, McAlhaney et al. 1985). Likewise, early studies characterized localization
of calpain-1 and calpain-2 isoforms in brain regions that are highly susceptible to
degeneration (Siman et al. 1985; Simonson et al. 1985; Hamakubo et al. 1986).
Calpain has since become a promising target for attenuation of secondary
damage in spinal cord injury. A study by Springer et al., showed that
pretreatment with Riluzole, an inhibitor of glutamate release, reduced loss of
MAP2 levels in rats following spinal injury (Springer et al. 1997). Several classes
of calpain inhibitors have provided modest protection when administered either
pre injury or post injury. Calpeptin, CEP-4143, and MDL-28170, are some of the
calpain inhibitors that demonstrated potential therapeutic effects.(Ray, Shields et
al. 1999; Schumacher, Eubanks et al. 1999; Schumacher, Siman et al. 2000;
Zhang, Bondada et al. 2003; Yu and Geddes 2007). CEP-4143 demonstrated
calpain isoform specificity in its ability to targetµ- calpain. Morphometric
assessment of tissue sparing, survival of neurons in the red nucleus, and
behavioral deficits were protected or improved when rats were pretreated with
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CEP-4143 (Schumacher, Siman et al. 2000). Studies using single and sustained
administration of MDL28170 showed improvements in tissue sparing and motor
behavior (Hung, Hwang et al. 2005; Yu and Geddes 2007). Although not
discussed here in detail, calpain has also been implemented in secondary
damage following traumatic brain injury (Posmantur et al. 1994; Farkas et al.
2005; Liu et al. 2006; Thompson et al. 2006; Deng et al. 2007).
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Figure 4.1. Simplified model of secondary injury cascade following traumatic
spinal cord and brain contusion. Ischemic conditions can lead to Ca2+ induced
mPTP formation and a compromise of mitochondrial function.
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The centralized hypothesis of the current study is that cyclophilin D null
mice (CypD-null) will show improved pathological outcomes following spinal cord
and cortical contusion. Previous literature has shown that pharmacological
inhibition of CypD improved pathological outcomes in rodent models of cortical
contusion. However, the protective effects of CypD have produced confounding
results following spinal cord contusion. Thus, it is uncertain if these
discrepancies are due to variances in pharmacological properties or regional
variations in the actions of CypD. By utilizing mice with a homozygous knockout
of CypD (encoding gene Ppif), we can directly assess the role of CypD in
secondary spinal and cortical injury. Our working model for the centralized
hypothesis is that ablation of CypD will attenuate formation of mPTP formation,
ultimately improving motor impairments, tissue sparing, and proteolytic enzyme
activation induced by secondary damage that follows the both spinal cord and
cortical contusion (Figure 4.2). To test our hypothesis, we constructed the
following specific aims:

Specific Aim One will test the hypothesis that CypD-null mice will show
improved motor function recovery following spinal contusion. The Basso Mouse
Scale will be used to assess changes in open field motor function.
Specific Aim Two will test the hypothesis that CypD-null mice will show
increased tissue sparing following spinal contusion and cortical contusion.
Histological assessment of total spared tissue, white matter, grey matter, and
lesion volume will be determined.
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Specific Aim Three will test the hypothesis that CypD-null mice will show
decreased calpain activity following spinal contusion and cortical contusion.
Western Blot analysis of calpain-mediated spectrin metabolism will be used to
determine calpain activity.
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Figure 4.2 Simplified Model of the central hypotheses. This model hypothesizes
that CypD knockout attenuates Ca2+ induced mPTP formation following
secondary damage
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Chapter Two
The Role of Cyclophilin D in Secondary Spinal Cord Injury
Introduction
The initial impact from traumatic spinal cord injury (SCI) can produce
catastrophic mechanical damage. However, in the ensuing hours and days
following the initial impact, a secondary wave of insults is initiated accelerating
tissue destruction several segments below the epicenter. This secondary
phenomenon is defined by disruption of Ca2+ homeostasis, free radical
production, and activation of necrotic and pro apoptotic cascades (Panter et al.
1990; Moriya et al. 1994; Popovich et al. 1996). The time line for secondary
injury presents a critical window for any therapeutic attempt to recover motor and
sensory function. A prominent driving mechanism of secondary tissue
degradation is an increase in mitochondrial permeability to any molecules < 1500
daltons (Hunter et al. 1976; Al-Nasser et al. 1986). The increase in mitochondrial
permeability causes massive swelling and disruption of the mitochondrial
membrane, uncoupling of oxidative phosphorylation in the electron transport
chain and subsequent down regulation of ATP production (Hunter et al. 1976;
Bernardi et al. 1996; Crompton 1999; Halestrap et al. 2002).
Though primarily driven by large influxes of Ca2+, it is the collective actions
of secondary insults that initiate the formation of a regulated, non-specific
megachannel within the mitochondria called the mitochondrial permeability
transition pore (mPTP) (Szabo et al. 1992; Bernardi et al. 1996; Bernardi et al.
1998; Crompton 1999; Sullivan et al. 2005; Smith et al. 2008). Ultimately, it is
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the formation of the mPTP that permits excessive ion permeability and disruption
of mitochondrial bioenergetics (Hunter et al. 1976; Al-Nasser et al. 1986). The
most characterized components of the mPTP include an outer membrane
component called the voltage dependent anion channel (VDAC) and the adenine
nucleotide translocase (ANT), which forms the inner membrane pore, both are
integral in mPTP formation, but are not a necessity in mPTP function (Bauer et
al. 1999; Gross et al. 2000; De Giorgi et al. 2002; Kokoszka et al. 2004; Baines
et al. 2005). A critical finding by Crompton and colleagues was the inhibition of
Ca2+ dependent mPTP opening by the immunosuppressive drug cyclosporine A
(CsA)(1988). Cyclosporine A mediates its actions by binding to and inhibiting the
mitochondrial matrix component cyclophilin D (CypD) from binding to ANT
(Crompton et al. 1998). CsA inhibited pore formation and subsequent
mitochondrial permeability, prompting the hypothesis that CypD is the regulating
component in mPTP formation (Crompton et al. 1988; Connern et al. 1994;
Crompton et al. 1998; Hansson et al. 2004).
CypD has since shown promise as a viable target for neurotrauma
protection. Recent reports demonstrated the ability of cyclosporine A and its
analog NIM811 to attenuate cortical damage in rodent models of TBI (Sullivan et
al. 2000; Mbye et al. 2008). However, administrations of these compounds in
SCI models have produced confounding results. CsA has not offered the same
extent of protection in SCI as seen in TBI, except in doses that are highly toxic
(Rabchevsky et al. 2001; Morota et al. 2007). NIM811 did offer moderate
protection at the cellular level and in functional outcome following SCI at safe
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doses (McEwen et al. 2007; Ravikumar et al. 2007). Thus, the question remains
as to whether these discrepancies are due to variances in pharmacological
properties or regional variations in the components and behavior of the mPTP.
The recent availability of transgenic mice with knockout of the CypDencoding gene Ppif has provided a unique opportunity to directly examine the
role of CypD in secondary SCI and TBI damage. We used these models to test
the overall hypothesis that ablation of CypD in mice will result in attenuation of
secondary injury in both spinal cord contusion and cortical contusion. Functional
recovery was assessed by measuring recovery of hind limb motor skills over a 4
week period. To assess the extent of tissue sparing, we employed a modified
eriochrome cyanine staining. Finally, calpain activity was measured according to
the metabolism of spectrin as determined by western blot. The results of our
studies show that homozygous knockout of CypD in mice offered no pathological
improvements and some cases worsened outcomes following spinal cord
contusion.
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Materials and Methods
Animals. All animals were housed in the Division of Laboratory Animal
Resources sector of the University of Kentucky Medical Center, which is fully
accredited by AAALAC. All experimental procedures abide by protocols approved
by the University of Kentucky's Institutional Animal Care and Use Committee.
These studies were performed using both WT and transgenic mice. The
transgenic mice (CypD-null) features a homozygous deletion of the CypD
encoding gene Ppif (peptidylprolyl isomerase F).

CypD-null mice were

generated on a chimeric strain using adult female C57BL/6 crossed to a SV129
strain (B6129) (Baines et al. 2005). The WT mice utilized were also B6129
purchased from Taconic.
Mouse Model of Traumatic Spinal Cord Injury. All experimental procedures were
conducted in accordance with the guidelines of the Institutional Animal Care and
Use Committee (IACUC) of the University of Kentucky. The spinal contusions
administered in these studies were conducted using the commercially available
Infinite Horizon (IH) spinal cord injury device (Precision Systems &
Instrumentation (PSI), Lexington, KY). The IH impactor allows for user defined
parameters to achieve the desired severity of injury. There are three parameters
measured by the IH impactor and defined as follows: 1. Force as the actual force
delivered by the impactor compared to the calibrated force, 2. Velocity as the
speed of the impactor tip as it delivers the contusion, and 3. Displacement as the
elasticity of the spinal cord required until the calibrated force is achieved. The
force of the contusion, measured in kilodyns, was calibrated according to each
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severity. For mild injury, a calibrated force of 30kdyn was used. For the
moderate injuries, a calibrated force of 50kdyn was used. Finally, for the severe
contusions, a calibrated force of 70kdyn was used. These settings were derived
from a previous study characterizing injury gradients in the mouse model (Basso
et al. 2006). Mice were anesthetized by an intraperintoneal injection ketamine
(80mg/kg) and xylamine(10mg/kg). Laminectomies were made to expose the
T10 vertebral segment. Two clamps were applied approximately at the caudal
T11 segment and the rostral T9 segment. The spinal cord was then lowered and
straightened until parallel with the platform. Sham animals received a
laminectomy only. Following surgery, all animals were placed on a heating pad
set at 37°C until consciousness and mobility (upper limbs) was regained.
Postoperative care included the manual expression of bladders twice daily until
recovery of bladder function, injection with 10 ml sterile saline administered
subcutaneously (s.c.) immediately after surgery, 33.3 mg/kg cefazolin,
administered by intramuscular injection, twice a day for 1 week then once a day
for the remaining 3 weeks.
Hind Limb Motor Function Assessment. Motor function following spinal cord
injury was measured by two raters blinded to the experimental conditions. Hind
limb motor function was measured using the Basso Mouse Scale (BMS), a 9
point categorical scale that rates seven observable motor functions and motor
deficits. The seven categories in the BMS included ankle extension, of hind limb
joint movements, trunk stability, stepping coordination, paw placement, and tail
position (Basso et al. 2006). A single score was recorded for the left and right
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hind limb which was then averaged to give a total score. An 11 point subscore
was obtained to assess subtle variations within each category. Each BMS test
was assessed by two examiners. One examiner is the main observer while the
other examiner observes and records the scores during the exam. This is to
ensure that one person is observing the test for the entire duration. Each trial is
4 minutes.
Histological Assessment of Spinal Cord Tissue Sparing. Mice were given an
overdose injection of pentobarbital followed by a cardiac perfusion of cold 1x
PBS and 4% PFA. Spinal cords blocks 2 cm in length, centered at the lesion
epicenter, were dissected, post-fixed in the same 4% PFA solution for 24 h at 4°C
followed by submersion in 25% sucrose solution at 4°C to ensure cryoprotection.
Spinal cords were cryosectioned at a thickness of 20microns and mounted onto
gelatin-coated slides and stored at -20C. For histological staining, the gelatincoated slides were allowed to thaw to room temperature. Each slide was then
cleared and hydrated in Citrisolv followed by ethanol concentration gradient.
Slides were then submerged in an eriochrome cyanine staining solution (10%
FeCl3 and .2% ECRC). The slides were submerged in a differentiation solution
for 10 seconds followed by a wash in H20 then allowed to dry overnight.
Spinal cord tissue was assessed using a modified eriochrome cyanine
staining protocol for myelin that stains for both white matter and neuronal cell
bodies. Tissue sparing was assessed from area measurements of white matter,
gray matter, and total lesion volume. Total tissue sparing is reported as a
percentage calculated as follows: 1-(Lesion area/ Total cross sectional area) x
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100. Spared white matter was calculated as follows: Total cross sectional area Lesion area - Gray matter area.
Spinal Cord Processing for Western Blot Analysis of Calpain Activity. Spinal
cords segments were thawed and cut into 10mm long sections containing the
injured site and weighed. The spinal sections were homogenized in 50mM 1X
TBS(Tris, NaCl, H20; pH 7.5). Spinal cord homogenates were spun at 32,000
rpm for 30 minutes to separate the supernatant and pellet. The pellets were
reconstituted in protease inhibitor with 2% SDS( 50mM TBS pH 7.5, .5M EDTA
pH 8.9, 100mM AEBSF, 10mM Leupeptin, 1.5mM Pepstatin) and spun at 32,000
rpm for 30 minutes and the supernatant recovered and frozen at -20OC. Brain
cortex samples thawed and weighed out. Both spinal cord and brain tissue were
homogenized in a 1X Tris-Saline with protease inhibitors (50mM TBS pH 7.5,
.5M EDTA pH 8.9, 100mM AEBSF, 10mM Leupeptin, 1.5mM Pepstatin) and
spun at 33,000 RPM for 20 minutes. Supernatant was recovered and frozen at 20OC. Samples were loaded at 20ug into a 6.5% gel followed by a transfer onto
a nitrocellulose membrane. The membranes were washed in 1X TBS then
blocked in 5% milk/1X TBS solution for 1 hour. For detection of spectrin in spinal
cord and brain cortex samples, membranes were incubated overnight with MAS
spectrin AB at 1:10,000 dilution in a 5 ml, 5% milk/1X TTBS solution (10XTBS,
Tween 20, D-H2O). Membranes were washed the following day in TTBS then
incubated with fluorescently conjugated secondary antibody solution at 1:5000 in
for 1 hour in a 5 ml, 5% milk/1X TTBS solution (10XTBS, Tween 20, D-H2O).
Membranes are then washed in 1X TTBS and visualized on Odyssey Imager.
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Statistical Analysis of Each Experimental Aim
IH impactor parameters: Data from the IH impactor were analyzed by two-tailed
unpaired Student’s t-Test. Significance was set at P<0.05, 95% C.I. Data
reported represents mean +/- STDEV. .
Hind limb motor assessment: Data from BMS test were analyzed by repeated
measures two-way ANOVA followed by Bonferroni post hoc test. Significance
was set at P<0.05. The two independent variables in this study are the mouse
type (WT and CypD-null) and time post injury. F scores are reported as F score
Interaction (F score Mouse, F score Time). Data reported represents mean +/STDEV.
Histological assessment of tissue sparing: Data recorded from histological
assessment of spinal cord tissue was analyzed by ANOVA followed by Tukey’s
multiple comparison post hoc test. Significance was set at P<0.05, 95% C.I.
Data reported represents mean +/- STDEV.
Calpain activity: Data from WB analyses of calpain activity were analyzed by
Two-way ANOVA followed by Bonferroni post hoc test. Significance was set at
P<0.05, 95% C.I. Data reported represents mean +/- STDEV. All Data were
analyzed using GraphPad Prism.
Inclusion and Exclusion Criteria: For the current study, animals subjected to
spinal cord contusion by the IH impactor must register a delivered calibrated
force +/- 5kdyns to ensure an appropriate contusion severity. Additionally,
animals must display post operative paralysis upon recovery from anesthesia, a
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time of approximately 1 hour. Animals must only display ankle extension or
ankle extension and plantar or dorsal placement of the paw without weight
support. This is a BMS rating of 3, though the data is not reported here. This
criterion is based on our pilot study which showed CypD-null mice subjected to
spinal contusion did not display an acute recovery and exhibited hind limb
paralysis as observed in WT mice. After 24h of recovery, no mouse model may
be excluded regardless of recovery rate. The only exception is death or illness
that prevents any further testing as determined by veterinarian staff.
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Results
Infinite Horizon Impact Parameters.
Table 1 displays the recorded Infinite Horizon (IH) impact parameters for all
spinal cord contusion studies. Table 1A shows that for mild spinal contusions,
there was no significant difference in force, displacement, or velocity of the
impact tip in CypD-null mice compared to WT mice. Table 1B shows that for
moderate spinal contusions, there was no significant difference in force,
displacement, or velocity of the impact tip in CypD-null mice compared to WT
mice. Table 1C shows that for severe spinal contusions, there was no significant
difference in force, displacement, or velocity.
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Mouse

Force (kDyn)

Displacement(microns)

Velocity(ms)

CypD-/-

32 +/- 2

264 +/- 25

122 +/- 1

WT

32 +/- 2

238 +/- 30

122 +/- 2

Mild Spinal Contusion
Mouse

Force (kDyn)

Displacement(microns)

Velocity(ms)

CypD-/-

53 +/- 2

499 +/- 84

123 +/- 2

WT

54 +/- 2

493 +/- 143

123 +/- 3

Moderate Spinal Contusion
Mouse

Force (kDyn)

Displacement(microns)

Velocity(ms)

CypD-/-

73 +/- 2

849 +/- 102

120 +/- 3

WT

73 +/- 1

811 +/- 72

124 +/- 4

Severe Spinal Contusion
Table 1 Infinite Horizon (IH) parameters for mild, moderate and severe spinal
cord contusion. A. For mild SCI, there were no significant differences in IH
parameters. B. For moderate SCI, there were no significant differences in IH
parameters. C. For severe SCI, there was a significant no significant difference in
IH parameters. Values=Mean +/- STDEV. Two tailed paired student’s t-test.
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Hind Limb Motor Function Assessment
The Basso Mouse Scale (BMS) analysis, a 9 point categorical scale, was
used to assess CypD-null and WT mice for open field motor function following
moderate, mild and severe SCI over a period of 4 weeks. Immediately following
spinal impact, both animal models displayed complete bilateral hind limb
paralysis as evident by ankle extension only or ankle extension plus plantar
placement without weight support for all gradients of contusion (data not shown).
This immediate observation was to assess the consistency of the contusion
across all models (Springer et al. 1997).
Figure 5.1A and B show that following moderate SCI, there was no
significant difference in BMS scores and subscores for functional motor recovery
between the two models after 4 weeks. However, both models did display
gradual improvement at 3 days post spinal contusion in ankle extension and
plantar placement. By the second week, both models showed further
improvements in plantar placement with weight support and stepping
coordination in addition to paw position and trunk stability. By week 3, both WT
and CypD-null regained most coordination and showed only mild trunk instability
as indicated by a side to side tail sway. The improvements observed at week 3
reached a plateau, as no greater improvements were observed in week 4.
Fig 5.2A and B show that following mild spinal contusion, there was no
was no significant difference in BMS scores and subscores for functional motor
recovery between the two models after 4 weeks. By 3 days post injury, both WT
and CypD-null displayed consistent plantar stepping, regained most coordination
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and displayed only mild trunk instability. By 1 week post injury motor recovery
skills had reached a plateau as no more improvements were observed for the
remaining 3 weeks.
Figure 5.3A and B show that following severe spinal contusion, there were
significant differences in BMS scores and subscores for functional motor
recovery between the two models at select time points after 4 weeks. Figure
5.3A shows a significant difference in BMS scores at weeks 1,2,3, and 4
[F=18.27(1027,44.65); p<.001]. By 1 week post injury, WT mice regained some
ability for weight supported stepping where as CypD-null showed only extensive
ankle extension with some plantar placement. WT mice continued to show motor
improvement with recovery of most coordination, consistent stepping, and an
upgrade in trunk instability from severe to mild. CypD-null mice failed to show
the same recovery over 4 weeks. CypD-null mice showed significantly lower
recovery at each time point from 1 week until 4 weeks of BMS testing. By 4
weeks testing, CypD-null mice displayed only occasional to frequent weight
supported stepping with recovery of some coordination. Trunk instability in
CypD-null mice never improved above severe. The poor motor recovery of
CypD-null mice is further illustrated by the BMS subscores in Figure 5.3B. CypDnull never achieved any subscore above 0 at any time point. WT mice also
achieved subscores of 0 from day three to the second week of testing. However,
at weeks 3 and 4 WT mice scored significantly higher BMS subscores as they
regained consistent plantar stepping and coordination [F=19.11(882.7,19.11);
p<.001].
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BMS Scores After Mild SCI

A
BMS Scale Rating

12

CypD-null Sham
WT S ham
CypD-null Injury
WT Injury

10
8
6
4
2
0
3d

1wk

2wk

3wk

4wk

Time Post SCI

B

BMS Subscores After Mild SCI

BMS Scale Rating

12

CypD-null Sham
WT Sham
CypD-null Injured
WT Injured

10
8
6
4
2
0
3d

1wk

2wk

3wk

4wk

Time Post SCI

Figure 5.1 Basso Mouse Scale(BMS) scores and subscores for WT and CypDnull sham and injured mice at 3d, 1wk, 2wk, 3wk, and 4wk post moderate injury.
A. No significant differences in BMS scores between WT injured and CypD-null
injured mice at any time point following moderate SCI. B. No significant
differences in BMS subscores between WT injured and CypD-null injured mice at
any time point following moderate SCI. Values=Mean +/- SD. Two-way ANOVA
and Bonferroni post hoc test. N=6 per injury group and 3 per sham group.
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BMS Scores After Moderate SCI
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BMS Subscores After Moderate SCI
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Figure 5.2 Basso Mouse Scale(BMS) scores for WT and CypD-null sham and
injured mice at 3d, 1wk, 2wk, 3wk, and 4wk post mild injury. A and B. No
significant differences in scores or subscores for WT injured and CypD-null
injured mice at any time point following mild SCI. Values=Mean +/- SD. Two-way
ANOVA and Bonferroni post hoc test. N=6 per injury group and 3 per sham
group.
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BMS Scores After Severe SCI
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BMS Subscores After Severe SCI

BMS Scale Rating

12
10

***

8

***

6

CypD-null Sham
WT Sham
CypD-null Injury
WT Injury

4
2
0
3d

1wk

2wk

3wk

4wk

Time Post SCI

Figure 5.3 Basso Mouse Scale(BMS) scores for WT and CypD-null sham and
injured mice at 3d, 1wk, 2wk, 3wk, and 4wk post severe injury. A. There was a
significant difference in BMS scores between WT injured and CypD-null injured
mice at select time points following severe SCI [***p<.001, F=18.27(1027, 44.65
) at 1wk, 2wk, 3wk, and 4wk]. B. There was a significant difference in BMS
subscores between WT injured and CypD-null2 injured mice at select time points
[***p<.001, F=19.11(882.7, 19.11) at 3wk and 4wk]. Values=Mean +/- SD. Twoway ANOVA and Bonferroni post hoc test. N=6 per injury group and 3 per sham
group.
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Histological Assessment of Spinal Cord Tissue Sparing
Following the 4th week of BMS analysis, all mice were euthanized and volumetric
measurements were conducted by histological assessment for total spared
tissue, white matter, and grey matter following moderate and severe spinal cord
injury. Histological staining showed that following moderate injury, both CypDnull and WT injured mice had the greatest spinal tissue loss at the impact site, or
the epicenter, with damage extending primarily in the caudal direction with some
injury extending in the rostral direction (Figure 6.1). The epicenter of injury in
both groups, approximated at the thoracic level of T-10, was characterized by a
dense fibrous matrix encompassing the cross sectional area of the tissue (Figure
6.1). This lesion was not present in WT or CypD-null sham mice (Figure 6.1).
Figure 6.2 shows the histological assessment for spared tissue following
moderate SCI. There was no significant difference in the volume of spared
tissue between CypD-null injured and WT injured mice (Figure 6.2A). Both
injured mice showed a significant reduction in spared tissue compared to both
sham mice [p<.01, F(24.61) for all injury vs shams]. A rostral to caudal expansion
of the percentage of spared tissue is represented in figure 6.2B. There was no
significant difference in the percentage of spared tissue at any spinal segment.
Figure 6.3 shows no significant reduction in lesion volume in CypD-null injured
mice compared to WT injured mice. Measurements of spared white matter
showed no significant improvements in CypD-null mice compared to WT mice as
measured by ANOVA (6.4A). A rostral to caudal expansion of spared white
matter area is represented in figure 6.4B. There was a statistical significant
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difference in white matter area at the most rostral section for CypD-null mice
compared to WT mice [p<.05, F=1.763(4.450,42.01)]. However, at this rostral
section, there is no measurable tissue damage and the increase white matter is
likely from compression of the rostral most segments during tissue mounting.
Measurements of spared gray matter showed no significant improvements in
CypD-null injured mice compared to WT mice (Figure 6.5A). A rostral to caudal
expansion of gray matter area is represented in Figure 6.5B. CypD-null mice
showed a statistically significant increase in grey matter area compared to WT
injured mice[p<.001; F=6.613(12.01,104.7)]. Again, at this rostral section there
was no measurable tissue damage.
Figure 7.1 shows histological assessment for spared tissue following severe SCI.
Figure 7.2A shows a significant reduction in the volume of spared tissue in CypDnull injured mice compared to WT inured mice [ p<.01; F(86.80); for CypD-null
injury vs sham; p<.001 all injury vs all sham]. A rostral to caudal expansion of
the percentage of spared tissue is represented in Figure 7.2B. CypD-null injured
mice showed a significant reduction in the percentage of spared tissue at select
sections both caudal and rostral from the epicenter compared to WT injured mice
[p<.01; F10.73(67.20, 182.2) at 1mm and -1mm; p<.001 at 2mm and -2mm].
Figure 7.3 shows no significant difference in lesion volume in CypD-null injured
mice compared to WT injured mice. Measurements of spared white matter
showed that CypD-null injured mice had a significant reduction compared to WT
injured mice (Figure 7.4A) [p<.01; F=(59.25)]. A rostral to caudal expansion of
the spared white matter area is represented in Figure 7.4B. CypD-null injured
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mice showed significant reductions in spared white matter at select sections both
rostral and caudal from the epicenter compared to WT injured mice [p<.01 at
1mm, 4mm, 6mm; p<.001 at 2mm, 3mm; F=4.744(108, 36.63)]. Figure 7.5A
shows that gray matter was also significantly reduced in CypD-null injured mice
compared to WT mice [p<.001; F=(71.87)]. A rostral to caudal expansion of
spared grey matter is represented in Figure 7.5B. CypD-null mice showed a
significant reduction in gray matter sparing at select sections both rostral and
caudal to the epicenter [p<.01 at -3mm, 5mm; p<.001 at 2mm, 3mm, 4mm, 6mm;
F=7.73(159.5, 89.14)].
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CypD - null Sham

WT
WT Sham
Sham

CypD -null Moderate Injury

WT Moderate Injury

-4mm

-3mm
Rostral

-2mm

-1mm

Epicenter

1mm

2mm

3mm
Caudal

4mm

Figure 6.1 Histological assessment showing rostral(-mm) to caudal(mm)
expansion of moderate injured spinal cord sections or laminectomy only (sham
models) in CypD-null and WT mice. The epicenter is the point of impact as
evident by large lesion volume. Lesions in the injured animal extend into the
caudal section below the epicenter.
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Spared Tissue in Moderate SCI
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Figure 6.2 Total tissue sparing for WT and CypD-null mice 4weeks post
moderate spinal contusion. A. The volume of total tissue sparing. No significant
difference in the volume of total tissue sparing was recorded in CypD-null and
WT injured mice. Values=Mean +/- STDEV. ANOVA and Tukey’s multiple
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comparison post hoc test. N=6 for injured group and N=3 for sham group. B.
The percentage of total tissue sparing represented in a caudal to rostral
expansion. No significant difference in the percentage of total tissue sparing was
recorded at any section at both caudal and rostral direction from the epicenter in
CypD-null and WT injured mice. Values=Mean +/- STDEV. Two-way ANOVA and
Bonferroni post hoc test. N=6 for injured group and N=3 for sham group.

Lesion Volum e in Moderate SCI
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Figure 6.3. Lesion volume for WT and CypD-null mice 4 weeks post moderate
spinal contusion. No significant difference was recorded in lesion volume
between WT and CypD-null injured mice. Values=Mean +/- STDEV. ANOVA and
Tukey’s multiple comparison post hoc test. N=6 for injured group and N=3 for
sham group.
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White Matter Sparing in Moderate SCI
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Figure 6.4 White matter sparing for WT and CypD-null mice 4 weeks post
moderate spinal contusion. A. Quantification of white matter sparing. No
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significant difference was recorded in the white matter sparing in CypD-null
injured mice compared to WT injured mice. Values=Mean +/- STDEV. ANOVA
and Tukey’s multiple comparison post hoc test. N=6 for injured group and N=3
for sham group. B. Rostral to caudal expansion of white matter sparing. White
matter sparing was significantly increased in CypD-null injured mice compared to
WT injured mice at rostral section -4mm from the epicenter. Values=Mean +/STDEV. *p<.05; Two-way ANOVA and Bonferroni post hoc test. N=6 for injured
group and N=3 for sham group.

Grey Matter Sparing in Moderate SCI
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Figure 6.5 Grey matter sparing for WT and CypD-null mice 4 weeks post
moderate spinal contusion. A. Quantification of grey matter sparing. No
significant difference in total tissue sparing in CypD-null injured mice compared
to WT injured mice. Values=Mean +/- STDEV. ANOVA and Tukey’s multiple
comparison post hoc test. N=6 for injured group and N=3 for sham group. B.
Rostral to caudal expansion of grey matter sparing. Grey matter sparing was
significantly increased in CypD-null injured mice compared to WT injured mice at
the caudal section -4mm from the epicenter. Values=Mean +/- STDEV. ***p<.01;
Two-way ANOVA and Bonferroni post hoc test. N=6 for injured group and N=3
for sham group.
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Figure 7.1 Histological assessment showing rostral(-mm) to caudal(mm)
expansion of severe injured spinal cord sections or laminectomy only (sham
models) in CypD-null and WT mice. The epicenter is the point of impact as
evident by large lesion volume. Lesions in the injured animal extend into the
caudal section below the epicenter.
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Spared Tissue in Severe SCI

A

***

Total Tissue Sparing Volume (mm3)

25
20

**

15

CypD-null Sham
WT Sham
CypD-null Injury
WT Injury

10
5

In
ju
ry
W
T

yp
D
-n
ul
lI
nj
ur
y

Sh
am

C

C

Rostral to Caudal Expansion
Spared Tissue in Severe SCI

B
125
Total Tissue Sparing Percent (%)

W
T

yp
D
-n
ul
lS

ha
m

0

100
75

*
*

***
***

CypD -/- Injury
WT Injury

**

50
25
0
-8 -7 -6 -5 -4 -3 -2 -1 0 1 2 3 4 5 6 7 8

Distance From Epicenter

Figure 7.2 Total tissue sparing for WT and CypD-null mice 4 weeks post severe
spinal contusion. A. Quantification of total tissue sparing. Total tissue sparing
was significantly decreased in both CypD-null and WT injured mice compared to
both sham models. Total tissue sparing was a significantly decreased in CypDnull injured mice compared to WT injured mice. Values=Mean +/- STDEV.
***p<.01; ANOVA and Tukey’s multiple comparison post hoc test. N=6 for injured
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group and N=3 for sham group. B. Rostral to caudal expansion of white matter
sparing expansion. There was a significant decrease in CypD-null injured mice
compared to WT injured mice at the rostral section of -1mm and -2mm and at the
caudal sections 1mm, 2mm, and 3mm from the epicenter. Values=Mean +/STDEV. *p<.05, **p<.01, ***p<.001; Two-way ANOVA and Bonferroni post hoc
test. N=6 for injured group and N=3 for sham group.
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Figure 7.3 Lesion volume for WT and CypD-null mice 4 weeks post severe
spinal contusion. No significant difference was recorded in lesion volume
between WT and CypD-null injured mice. Values=Mean +/- SD. N=6 for injured
group and N=3 for sham group.
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Figure 7.4 White matter sparing for WT and CypD-null mice 4 weeks post
severe spinal contusion. A. Quantification of white matter sparing volume. White
matter was significantly decreased in CypD-null injured mice compared to WT
injured mice. Values=Mean +/- STDEV. **p<.01, ***p<.001. Data by ANOVA and
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Tukey’s multiple comparison post hoc test. N=6 for injured group and N=3 for
sham group. B. Rostral to caudal expansion of white matter sparing. White
matter sparing was significantly reduced in CypD-null injured mice compared to
WT injured mice (**p<.01 at the caudal section at 1mm, 4mm; ***p<.001 at 2mm,
3mm, 6mm). Data by Two-way ANOVA and Bonferroni post hoc test. N=6 for
injured group and N=3 for sham group. Values=Mean +/- STDEV.
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Figure 7.5 Grey matter sparing for WT and CypD-null mice 4 weeks post severe
spinal contusion. A. Quantification of grey matter sparing volume. Grey matter
was significantly decreased in CypD-null injured mice compared to WT injured
mice. Grey matter was significantly decreased in CypD-null and WT injured mice
compared to CypD-null and WT sham mice (***p<.001 for all shams vs all injured
and CypD-null injured vs WT injured). Data by ANOVA and Tukey’s multiple
comparison post hoc test. N=6 for injured group and N=3 for sham group.
Values=Mean +/- STDEV. B. Rostral to caudal expansion of grey matter sparing.
Grey matter sparing was significantly reduced in CypD-null injured mice
compared to WT injured mice(**p<.01 at -3mm, 5mm; ***p<.001 at -2mm, 2mm,
4mm, 6mm). Data by 2way ANOVA and Bonferroni post hoc test. N=6 for
injured group and N=3 for sham group. Values=Mean +/- STDEV.
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Western Blot Analyses of Calpain activity following Moderate SCI
Calpain activity, as measured by calpain mediated spectrin metabolism
was assessed 24 hours following moderate spinal cord contusion. Western blot
analysis of SBP produces three distinct bands. Total intact spectrin, defined as
spectrin levels before enzyme catalysis, produces a specific band at 280kDa.
Total spectrin breakdown product (tSBP), defined as combined calpain and
caspase mediated metabolism of spectrin, produces a band at 150kDa. Calpain
mediated spectrin (cSBP), defined at metabolism of spectrin exclusively by
calpain, and produces a specific band at 145 kDa.
Figure 8.1A shows western blot analysis of total spectrin levels 24 hours
following moderate SCI. Figure 8.1B shows that CypD-null injured mice had no
significant decrease in total spectrin levels mice compared to injured WT mice or
compared to both mouse sham models. Figure 8.2A shows western blot analysis
of tSBP 24 hours following moderate SCI. There was no significant decrease in
calpain mediated SBP in injured CypD-null mice compared to injured WT mice.
Figure 8.2 B shows no significant difference in cSBP in CypD-null injured mice
compared to WT injured mice. There was a significant difference in calpain
specific SBP in injured injured WT mice compared to both mouse sham models
[p<.001; F(9.595)].
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Figure 8 Western blot and quantative analysis of total spectrin and SBP in CypDnull and WT sham and injured mice 24h post SCI. A. Quantitative analysis of
total spectrin levels (280kDa) shows no significant difference in CypD-null and
WT sham and injured mice. B. Quantitative analysis of total SBP (150kDa)
shows no significant difference in CypD-null and WT sham and injured mice. C.
Quantitative analysis of calpain-mediated SBP (145kDa) shows a significant
difference in WT injury compared to CypD-null and WT sham (**p > .01). Data
measured by ANOVA with Tukeys Multiple Comparison post hoc test. N=4 per
group. Values=Mean +/- STDEV.
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Discussion
The principal finding in our study was that mice with a homozygous knockout of
CypD, the regulatory component in mPTP formation, showed no significant
improvement in motor function, tissue sparing, or calpain activity following spinal
contusion. The purpose of this study was to assess the role of CypD in
neuroprotection following spinal cord and brain injury. Recent reports have
shown confounding results in the efficacy of CypD as a therapeutic target in SCI
(Rabchevsky et al. 2001; Ravikumar et al. 2007). Following brain injury,
treatment with the CypD inhibitor cyclosporin A improved behavioral function and
cortical tissue sparing (Sullivan et al. 2000; Sullivan et al. 2004). However, the
same dose regiment of cyclosporine A failed to provide protection following SCI
(Rabchevsky et al. 2001). The only protection following SCI observed from
cyclosporin A was elicited at toxic doses. In contrast, a recent study using
NIM811, a non immunosuppressive cyclosporin derivative, recorded decreased
lesion size, preserved mitochondrial bioenergetics, and improved tissue sparing
and motor function following spinal cord injury (McEwen et al. 2007; Ravikumar
et al. 2007). Thus, the role of CypD in neuroprotection following spinal cord
injury remains uncertain.
In the current study, we directly addressed the role of role of CypD in SCI
by utilizing mice deficient for CypDl. The first assessment for improved outcome
following injury was hind limb motor function using the Basso Mouse Scale
(BMS) for 4 weeks following different severities of SCI. The mild contusion
produced very minimal motor deficits in both CypD-null and WT mice. This rapid
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recovery of motor function in both models would make any protective effects of
CypD-null difficult to assess. Following a moderate contusion, both WT and
CypD-null mice displayed complete hind limb paralysis immediately following the
injury. However, both WT and CypD-null mice showed similar recovery from the
moderate contusion. These results may question the sensitivity and selectivity of
the BMS as a means for measuring motor function following spinal contusion.
Some motor deficits, such as those resulting from gray matter damage, may be
masked by white matter damage and go undetected by BMS measurement.
However, this seems unlikely since spinal contusions were administered at the
lower thoracic level of T10. Motor neurons and interneurons of the grey matter at
this level primarily innervate axial muscles, having minor contributions to hind
limb motor function. Thus, lesions around the T-10 area produce motor deficits
that are mostly exclusive to white matter damage (Magnuson et al. 1999). It is
possible that a moderate contusion does not produce a strong enough motor
deficit to truly assess subtle changes. Within the first week following the
moderate spinal contusion, WT mice demonstrated an approximate 30%
recovery in function. WT mice were able to regain full weight support, most of
their coordination with only minor irregular paw placement. Such extensive
recoveries may make assessment of discrete motor improvements difficult.
To address this concern, we administered a severe spinal contusion.
Surprisingly, CypD-null mice failed to achieve the same level of motor recovery
as WT mice. Though, both mice did display complete hind limb paralysis
following contusion, only WT mice showed gradual recovery of motor function
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over the 4 weeks. CypD-null mice never achieved the same level of motor
recovery as WT from the first week until the final fourth week. These data
suggest that a basic physiological level of functional CypD is necessary for cell
survival. These data clearly show that CypD knockout in mice offers no
improved motor recovery following spinal cord injury regardless of the severity.
Impairments in locomotor function are indicative of axonal damage and to
an extent, gray matter damage. Based on our results from the BMS assessment,
it is not surprising that CypD-null mice showed no further improvement in any of
the tissue measurements following moderate injury. Both WT and CypD-null
mice displayed epicenter lesions consistent with previous measurements of
gradient contusions in various mouse strains (Kuhn et al. 1998; Jakeman et al.
2000; Ghasemlou et al. 2005). However, the extension of the lesion was mostly
exclusive to sections caudal to the epicenter. Again, these results are
contradictory to previous findings in rodent models of spinal cord injury (McEwen
et al. 2007; Ravikumar et al. 2007).
A possible explanation for these discrepancies, at least in spared tissue
assessment, may stem from species specific inflammatory responses following
SCI that mediate degeneration and healing (Zhang et al. 1996; Guth et al. 1999;
bZhang et al. 2003; Sroga et al. 2003). The fibrous matrix of connective tissue,
as shown at the epicenter, is in sharp contrast to the cyst-like fluid cavitation of
the epicenter observed in rats (Sroga et al. 2003). Mice follow a unique
secondary response compared to rats in which delayed inflammatory cell
infiltration may contribute more towards wound healing instead of secondary

70

neurodegenertion (Guth et al. 1999; Sroga et al. 2003). Any protective effects of
CypD ablation may be masked by a more universal healing mechanism in the
mouse model. Though, rats do display cellular markers of wound repair, these
events are largely overwhelmed by destructive inflammatory reaction (Sroga et
al. 2003). Thus, the effects that CypD ablation or other therapeutic strategies
may have on tissue sparing may be more evident in rats at earlier stages of
secondary response.
If this were the case, the unique healing response in mice would be
expected for all severities of spinal contusion. When we administered a severe
contusion, WT mice did display a similar epicenter lesion as measured during
moderate contusion. In CypD-null mice, however, the entire epicenter was
encompassed by a lesion that persisted in sections above and below the site of
injury. In moderate contusions, lesion reduction was seen in the immediate
sections below the site of injury. Furthermore, the decreased tissue sparing in
CypD-null mice compared to WT mice suggest that CypD may be necessary for
cellular support in the spinal cord following a severe injury.
Cellular alterations following spinal cord injury may offer a more discrete
assessment of the mechanisms involved in secondary damage, particularly in the
acute intermediate stages of injury. The secondary pathophysiological events
that follow spinal injury activate and mobilize deleterious catalytic proteins
(Anderson et al. 1993; Lynch et al. 1994; Moriya et al. 1994). A selection of
these catalytic proteins may be activated following mPTP formation. Of particular
interest is the sustained activation of Ca2+ dependent calpains. Extensive

71

studies of calpain have demonstrated their involvement in cell structural damage
and mediation of apoptotic and necrotic death (Wingrave et al. 2004; Momeni et
al. 2006; Deng et al. 2007; Momeni et al. 2007). Two recent studies showed that
onset of mPTP activated calpain, an effect that was blocked by administering
cyclosporine A (Ding et al. 2002; Ferrand-Drake et al. 2003). Increased
activation of the calpain isoform Calpain 1 has also been documented within 1h
and as far out as 24h following spinal injury in rats (Springer et al. 1997). These
reports demonstrate that calpain activation can result from mPTP opening.
Thus, we hypothesized that CypD ablation would mediate protective
effects by decreasing calpain activity, as measured by spectrin metabolism
(cSBP). However, our data showed that cSBP was not reduced in CypD-null
mice compared to WT mice. Though, cSBP was measured at 24h post injury,
other reports have shown that calpain is still elevated at this time (Springer et al.
1997). Additional time points closer to the time of injury may produce stronger
effects, calpain activity at 24h is still a viable time point. It is unlikely that calpain
has a minor role in secondary damage, as cSBP is elevated in both WT and
CypD-null injured mice compared to sham models. Thus, calpain activity may be
a critical mediator of secondary damage in spinal cord injury. However, the
metabolism of spectrin may not be indicative of the extent of calpain-induced cell
death. Additional substrates of calpain may provide more sensitive
measurements.
The potential for CypD as an effective target in spinal cord inury remains
uncertain. The results reported here and in previous studies have been
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conflicting and difficult to interpret. Several scenarios exist that may explain why
protection from targeting CypD is still elusive.
Spinal mitochondria have an inherent vulnerability even under
physiological conditions. This is evident by alterations in spinal mitochondrial
intrinsic properties, such as a basic lowered calcium retention, reduced mPTP
threshold, and a hampered Ca2+ transport and buffering system (Sullivan et al.
2004; Sullivan et al. 2005; Morota et al. 2007). Spinal neurons also show
increased ROS and subsequent lipid peroxidation and DNA oxidation compared
to cortical neurons (Sullivan et al. 2004). Thus, spinal neurons are readily
susceptible to insult making therapeutic protection difficult. The intrinsic nature of
spinal mitochondria becomes a greater factor when considering the complex
pathology of spinal cord injury. Though, cypD can induce both necrotic and
apoptotic cell death, it is the collective actions of several degenerative pathways
that may illicit the greatest damage (Schneider 2005; Forte et al. 2007)).
Apoptosis is a major inducer of secondary pathology following spinal cord
injury and is suggested to be the primary mediating cause of glial cell death
(Beattie et al. 2000). For example, oligodendrocytes, supportive glial cells that
are fundamental to maintaining axonal integrity, readily undergo apoptosis
following spinal cord injury. Inhibition of FAS and p75, receptor targets for
apoptotic stimuli, has shown to reduce cell death and improve axonal
preservation in rodent models of spinal cord injury (Casha et al. 2001; Casha et
al. 2005; Ackery et al. 2006). Additional studies have shown that attenuation of
other apoptotic stimuli, such as BAX, Bcl-2, and Fas ligand, resulted in improved
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behavioral outcome and increased tissue sparing (Genovese et al. 2008;
Genovese et al. 2008; Nocentini et al. 2008; Xu et al. 2009). In contrast, a recent
study showed that mitochondria isolated from CypD-null mice were not resistant
to BAX and Bcl-2 release of cytochrome C, an apoptotic-inducing agent, from the
mitochondrial inner membrane (Nakagawa et al. 2005). Thus, increased
mitochondrial permeability following spinal cord injury, as induced by apoptotic
factors, may occur even in the absence of CypD.
Interestingly, several of the studies mentioned above were using
pharmacological agents targeting multiple inflammatory processes involved in
secondary spinal cord injury. For example, a study from Genovese et al. showed
that inhibition of the MAPK signaling cascade reduced key inflammatory
mediators, such as neutrophil infiltration, pro inflammatory cytokine expression,
and nuclear factor-kappaB activation, in addition to apoptotic markers (Genovese
et al. 2008). Another study from Xu et.al, used a combinational therapeutic
approach of anti-inflammatory agents and showed similar reduction of apoptotic
and inflammatory markers in compression models of spinal cord injury in rodents
(Xu et al. 2009). The effectiveness of these treatments suggests that
inflammatory responses following spinal cord injury may be the prominent
mediator in secondary damage. Inflammatory responses can induce
excitotoxicity and subsequent Ca2+ increase, which presents a favorable
mechanisms for CypD mediated cell death (Beattie et al. 2000). However, these
studies, in addition to our findings, suggest that other inflammatory factors,
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particularly apoptosis, may largely be responsible for secondary damage
independent of CypD-mediated pathways.
Though, multiple secondary cascades may overwhelm CypD
mechanisms, the failed protective effects of targeting CypD may concern the
anatomical makeup of the spinal cord. CypD inhibition has shown to offer
modest protection in animal models of brain injury (Sullivan et al. 2000; Mbye et
al. 2008). The underlying cortical regions in the brain consist of vast gray matter
enriched in neuronal cell bodies. In these cortical regions, CypD has been
reported to be highly localized within neuronal mitochondria and to a greater
extent the post synaptic mitochondria (Naga et al. 2007; Hazelton et al. 2009;
Wang et al. 2009). In contrast, the lower thoracic segments, as targeted in our
model of spinal cord contusion, consist largely of axonal tracts with scarce
neuronal cell bodies. Contusions in regions of the spinal cord where there is a
greater area of gray matter, such as the cervical enlargement or the lumbar
sections containing the central pattern generator, may show a more pronounced
role for CypD following injury. Other regional variations may stem from mPTP
core components. Some exciting new studies in the identity and characteristics of
the mPTP structure may provide clues to the discrepancies seen in SCI
protection. Basso et al., revealed that the inhibitory effects of cyclosporine A and
NIM811 are dependent on the binding of phosphates to inhibitory regions on the
mPTP(Basso et al. 2008). In addition, Leung et al., revealed that an additional
mPTP component, the phosphate carrier, can induce mPTP opening in a Ca2+
dependent manner (Leung et al. 2008).
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The date presented here showed that CypD-null mice showed no
improved outcome following spinal cord injury. However, this is not to say that
CypD has no role in the the pathology of spinal cord inury. CypD may have a pro
survival role in the spinal cord, at least under severe injury. This concept has
been suggested in a recent study from Wang et al. Following hypoxic-ischemic
(HI) brain injury, Wang showed that immature CypD-null mice were more
susceptible to injury following hypoxic-ischemic (HI) brain injury. Furthermore,
induction of HI-induced brain injury in immature CypD-null mice was largely
dependent on apoptotic mechanisms. In adult CypD-null mice, the mechanism of
HI brain injury shift to CypD-dependent pathways (Wang et al. 2009). A potential
dual role for CypD in the spinal cord is intriguing. A possible model may show
that spinal cord cells, particularly oligoglial cells, require some active CypD to
maintain function. Our models using a homozygous deletion of CypD may
support this phenomenon.
Basal levels of CypD activation, under strict regulation, may contribute to
the preservation of mitochondrial integrity. Uncoupling proteins have been
shown to control the production of reactive oxygen species (ROS) in rodent
models of brain injury (Davis et al. 2008; Davis et al. 2008). Consider that mPTP
formation and the subsequent increased permeability disrupt oxidative
phosphorylation. If CypD-mediated mPTP formation can occur in a brief
controlled burst, this may allow for momentary reduction of any ROS production.
In addition, increased lipid peroxidation can produce clusters of misfolded
proteins that form unregulated pores in the mitochondria membrane (He et al.
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2002). CypD, as a molecular chaperone, may properly fold these clustered
proteins into a regulated channel (He et al. 2002). Thus, the protection recorded
using NIM811 still permits populations of mitochondria with functional CypD.
Complete ablation of CypD presents an extreme environment that increases
susceptibility as the injury becomes more severe. A study using heterozygous
knockout of CypD may support such a dual model of CypD.
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Conclusion
These studies show the differing role of CypD in secondary neurological
injury. CypD-mediated mitochondrial permeability is a dynamic factor in cell
death. Therapeutic strategies that target CypD may offer protection following
neurological injury. However, these studies show that the contributions of CypD
differ in selective models of injury. In the pathological time course of spinal cord
injury, CypD-mediated mechanisms may have only minor involvement. In
circumstances of severe spinal injury, CypD may actually be necessary for basic
function of surviving neuronal and glial cells. However, CypD-mediated death
may have a larger role in other neurological injuries, specifically brain injury.
Previous reports have shown that targeting CypD offers modest improvements in
cortical damage. Such functional diversity demonstrates that strategies aimed at
single pathological mechanisms may not be sufficient. In the event of spinal cord
injury, consideration must be given to several factors. Injury severity, regional
and temporal factors may all reveal dual functions for CypD and CypD-mediated
pathways of cell death. Further investigation is warranted concerning the
regional variation of CypD properties in the spinal cord and brain. A better
understanding of these regional discrepancies can lead to more effective
therapeutic intervention in spinal cord injury.

.
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Chapter Three
The Role of Cyclophilin D in Traumatic Brain Injury

Introduction
CypD has shown promise as a viable target for neurotrauma protection.
Recent reports demonstrated the ability of cyclosporine A and its analog NIM811
to attenuate cortical damage in rodent models of TBI (Sullivan et al. 2000; Mbye
et al. 2008). However, administrations of these inhibitors following spinal cord
contusion rodent models produced confounding results. Cyclosporine A has not
offered the same extent of protection in SCI as seen in TBI, except in doses that
are highly toxic (Rabchevsky et al. 2001; Morota et al. 2007). NIM811 did offer
moderate protection at the cellular level and in functional outcome following SCI
at safe doses (McEwen et al. 2007; Ravikumar et al. 2007). Furthermore, we
recently showed that mice with a homozygous deletion of CypD encoding gene
Ppif offered no increased protection from secondary damage following spinal
cord contusion. These discrepancies may be attributed to regional differences in
brain and spinal cord pathologies that may subsequently alter drug efficiency.
We sought to assess if this cortical protection would be consistent in our
CypD-null mouse model. We hypothesized that CypD-null mice will have
improved pathological outcomes following cortical contusion. To test this
hypothesis, we employed a modified eriochrome cyanine staining for histological
assessment of spared cortical tissue. The results of our study show that ablation
of CypD in mice is protective in tissue sparing following cortical contusion.
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Materials and Methods
Animals. All animals were housed in the Division of Laboratory Animal
Resources sector of the University of Kentucky Medical Center, which is fully
accredited by AAALAC. All experimental procedures abide by protocols approved
by the University of Kentucky's Institutional Animal Care and Use Committee.
These studies were performed using both WT and transgenic mice. The
transgenic mice (CypD-null) features a homozygous deletion of the CypD
encoding gene Ppif (peptidylprolyl isomerase F). CypD-null mice were
generated on a chimeric strain using adult female C57BL/6 crossed to a
SV129F1 strain (B6129F1) (Baines et al. 2005). The WT mice utilized were also
B6129 purchased from Taconic.
Mouse Model of Traumatic Brain Injury. The cortical contusions administered in
these studies were conducted using a commercially available impactor from
Precision Systems & Instrumentation (PSI), Lexington, KY). According to PSI, the
pneumatic driven IH cortical impactor uses a contact sensor that enables a more
accurate determination of the cortical surface prior to contusion. There are three
parameters measured by the IH cortical impactor and defined as follows: Force
(kdyn) as the actual force delivered by the impactor compared to the calibrated
force, 2. Velocity (ms) as the speed of the impactor tip as it delivers the
contusion, and 3. Dwell Time (mm) as the elasticity of the cortex required until
the calibrated force is achieved. Thee contact velocity is user controlled allowing
different degrees of cortical deformation to achieve the desired injury severity. In
these experiments, the contact velocity of the impactor was set at 3.5 ms to
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induce a moderate cortical contusion of .5mm. Mice were initially anesthetized in
a Plexiglas chamber using 4.0% isoflurane and placed in a stereotaxic frame
(David Kopf, Tujunga, CA, USA). Anesthesia was maintained throughout the
entire surgery with 2.5% isoflurane delivered via a nose cone. The head was
positioned on a horizontal plane with the nose bar set at zero. After a midline
incision exposing the skull, an approximate 4.0 mm craniotomy was made lateral
to the sagittal suture and centered between bregma and lambda. The craniotomy
section was carefully removed to avoid excessive perturbance of the dura under
the skull cap. The exposed cortex was injured using a pneumatically controlled
impactor device with a 3.0 mm flat-tip diameter. After injury, the craniotomy was
closed by placement of a small disk of saline-moistened Surgical over the dura,
followed by gluing a 6.0 mm disk made of dental cement over the site with super
glue. The animals were placed on a heating pad set at 37°C until consciousness
and mobility was regained.
Histological Assessment of Cortical Tissue Sparing. At 7 days post surgery,
mice were given an overdose injection of pentobarbital followed by a cardiac
perfusion of cold 1x PBS and 4% PFA. Whole brain were dissected, post-fixed in
the same 4% PFA solution for 24 h at 4°C followed by submersion in 25% sucrose
solution at 4°C to ensure cryoprotection. Whole brains were cryosectioned at 25µm
thickness and mounted onto gelatin-coated slides and stored at -20C. For
histological staining, the gelatin-coated slides were allowed to thaw to room
temperature. Each slide was then cleared and hydrated in Citrisolv followed by
ethanol concentration gradient. Slides were then submerged in a Cresyl stain
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(1M acetic acid, sodium acetate, d H20, cresyl violet acetate). The slides were
submerged in d H20 followed by a reverse ethanol concentration gradient.
Ipsilateral and contralateral cortical sections were assessed for percentage of
spared tissue and lesion volume.
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Results
Histological Assessment of Spinal Cord Tissue Sparing
At 4 week post cortical contusion or craniotomy, all mice were euthanized and
volumetric measurements were conducted by histological assessment for total
spared tissue and lesion volume. Histological staining showed that following
moderate contusion, both CypD-null and WT injured mice had the greatest spinal
tissue loss at the impact site, or the epicenter, with damage extending
Figure 9 shows spared tissue and lesion volume assessment in CypD-null and
WT injured mice following moderate cortical contusion. The percentage of
spared tissue was calculated from measurements taken from the contralateral
cortex of each animal (Figure 9A). Analysis by two-tailed t-test showed that
CypD-null mice had significantly greater tissue sparing compared to WT mice
(Figure 9A)(p<.01). Lesion volume was also measured in CypD-null and WT
injured mice (Figure 9B). Analysis by two-tailed t-test showed that CypD-null
mice had a significant reduction in lesion volume compared to WT mice (p<.05).
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Figure 9 Total tissue sparing for WT and CypD-null mice 1 week post moderate
cortical contusion. A. Percentage of total tissue sparing. CypD-null injured mice
had significantly greater tissue sparing compared to WT injured mice.
Values=Mean +/- SD. **p<.01, t=3.387. Two-tailed unpaired student’s t- test.
N=10,11 for injured group. B. Lesion volume. CypD-null injured mice had a
significant reduction in lesion volume compared to WT injured mice.
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Values=Mean +/- SD. *p<.05, t=2.662. Two-tailed unpaired student’s t-test.
N=10,11 for injured group.
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Discussion
The principal finding in our study was that mice with a homozygous
knockout of cyclophilin D, the regulatory component in mPTP formation, showed
significant improvement in cortical tissue sparing following moderate cortical
contusion. The purpose of this study was to assess the role of CypD in
neuroprotection following traumatic brain injury. Previous literature has shown
CypD to be a viable target for neurological protection in rodent models of
traumatic brain injury. Cyclosporin A and NIM811, both potent inhibitors of
CypD, improved motor function, increased cortical tissue sparing, and reduction
in calpain-mediated cytoskeleton degradation following cortical contusion in rats
(Mbye et al. 2008; Mbye et al. 2008; Wang et al. 2009). However, following spinal
cord injury, these same CypD inhibitors produced contradictory results.
Our preliminary findings support CypD as a viable target for attenuating
secondary brain injury. One week following administration of a moderate cortical
contusion, CypD-null mice showed improved tissue sparing and a reduction in
lesion volume compared to WT mice. Interestingly, we recently showed that
CypD-null mice had no improved outcome following spinal cord contusion.
These findings suggest that both physiological and pathological differences in
brain injury compared to spinal cord injury greatly affect the properties of CypD.
Post traumatic mitochondrial dysfunction and permeability, for example, is
readily induced due to Ca2+ overload following cortical injury. Mitochondrial
Ca2+ overload can also activate various mitochondrial free radicals that induce
mPTP formation and mitochondrial dysfunction in a CypD dependent manner
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(Ghafourifar et al. 1997; Richter et al. 1997; Mbye et al. 2008). Furthermore,
CypD was shown to be highly localized to synaptic mitochondria in the cortex
(Naga et al. 2007). These factors create a unique environment that is highly
susceptible to CypD-regulated injury in cortical injury. This is not to dismiss the
importance of mitochondrial dysfunction and mPTP activity in spinal cord injury.
However, the complex pathology of secondary spinal cord injury may induce
formation of mPTP mitochondrial dysfunction independent of CypD regulation.
Likewise, other secondary cascades, such as glial apoptotic death, may be the
primary contributor to secondary spinal cord injury.
The data presented in this study further supports CypD as a promising
target for attenuating the secondary damage in brain injury. Future studies
should assess additional pathological outcomes following brain injury using
CypD-null mice. Measurements of behavioral outcomes, such as motor and
cognitive function, may show additional protective effects of CypD ablation.
Another intriguing study would be measurement of mitochondrial bioenergetics in
CypD-null mice following brain injury. This should further confirm if the improved
mitochondrial function, as demonstrated with CypD pharmacological inhibition in
rats, is actually exclusive to CypD (Sullivan et al. 2000; Mbye et al. 2008).
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Chapter Four
Summary and Conclusions
Traumatic spinal cord and brain injury pathology consist of the primary
injury and secondary injury. The primary injury is the immediate damage induced
by the initial mechanical contusion. In the ensuing hours, days, and weeks a
secondary cascade of deleterious events accelerates the pathological damage.
Intervention and attenuation of primary damage is difficult due to rapid onset
following the injury. The events occurring in secondary damage, however,
present a unique window of opportunity for therapeutic attention. Thus, a
thorough understanding of the pathological mechanisms in secondary damage
will allow for more effective pharmacological and critical treatment following
traumatic spinal cord and brain injury.
Recently, cyclophilin D (CypD), the regulating component in mitochondrial
permeability transitional pore formation (mPTP), has shown promise in
attenuating secondary damage in brain injury. However, the role of CypD in
spinal cord injury is still uncertain. In this series of studies, we utilized mice with
a homozygous knockout of CypD in models of both spinal cord and brain injury.
We were able to directly assess the role of CypD in spinal cord injury through
measurements of motor function, tissue sparing, and calpain activation. We
hypothesized that CypD-null mice would have improved pathological outcomes
following spinal cord and brain injury.
Our first study utilized the Basso Mouse Scale (BMS) to measure hind
limb motor function for 4 weeks following different severities of spinal contusions
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CypD-null mice. Following both mild and moderate spinal contusion, CypD-null
showed no greater recovery of motor function than WT mice. However, an
unexpected outcome was produced when we administered a severe spinal
contusion. Motor impairment was exacerbated in CypD-null compared to WT
mice.
Our next study was a histological assessment of tissue sparing using
eriochrome cyanine staining procedure that specifically stains white matter. This
procedure was employed immediately following the 4th week of BMS testing. We
measured total spared tissue, lesion volume, and white and grey matter. The
results of our histological measurements were consistent with our BMS results.
In our moderate spinal contusion model, CypD-null mice showed no improved
sparing of tissue. Following severe spinal contusion, CypD-null mice showed a
decrease in tissue sparing compared with WT mice.
We concluded this series of studies by measuring calpain activity 24 hours
following moderate spinal cord contusion. Potentially, CypD-mediated death may
be more prominent in the immediate stages of secondary injury. We selected
calpain based on previous literature that showed elevated calpain activity
following spinal cord injury. This increased calpain activity was attenuated when
CypD was inhibited. However, our Western Blot analysis of calpain, measured
as calpain metabolism of spectrin, showed that CypD-null mice had no reduction
in calpain activity compared to WT mice.
Though pharmacological inhibition of CypD has shown to be protective
following brain injury, we wanted to confirm these findings using our transgenic
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model. We presented some preliminary data showing that CypD-null mice had
increased cortical tissue sparing and decreased lesion volume following a
moderate cortical contusion. Future studies should further assess additional
improvements in brain injury pathology using CypD-null mice.
In addition to our studies with CypD-null mice, we presented some
preliminary data on the protective effects of NIM811 in SCI. NIM811 was shown
to have protective effects following SCI. However, those studies used rats for
modeling SCI. Thus, we wanted to examine the effects of NIM811 in mice. Our
results showed that NIM811 modestly improved motor function in WT mice.
These improvements were observed at two weeks and three weeks following the
spinal cord injury.
In summary, our studies show that CypD is a viable target for attenuating
damage following cortical contusion. These protective effects were not observed
in our models of SCI. We showed that CypD-null mice showed no improvements
following moderate spinal cord injury. However, the exacerbated deficits
observed following severe injury suggest that some basic level of functional
CypD is necessary for cell survival.
This may seem contradictory as NIM811 did show moderate protection in
rat models following SCI and in our study using mouse models. However, drug
inhibition of CypD does not affect all populations of mitochondria. Thus, there is
still functional CypD to maintain its physiological activity. It is also feasible that
NIM811 interacts with additional proteins other than CypD. We did not examine
the effects of NIM811 in CypD-null mice following SCI. This would be an
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intriguing study as it may reveal unique characteristics of NIM811 as well as
mPTP regulation.
These data warrant further investigation into the efficacy of targeting CypD
in SCI. However, we provided some promising preliminary data showing another
potential target for attenuating secondary spinal cord damage. We assessed the
role CAPN5, a member of the calpain family, in spinal cord pathology. The
results from our study showed that CAPN5 deficient mice had greater recovery in
motor function following a severe spinal contusion. CAPN5 was previously
shown to be ubiquitously expressed in the rat brain and spinal cord and that it
has Ca2+ binding domains. Thus, CAPN5 may have similar proteolytic activity as
other typical mammalian calpains. Studies have shown that inhibiting calpain
can attenuate some of the pathological damage following SCI and TBI. Thus,
identifying calpain members that contribute to secondary cell death is critical.
Our results suggest that CAPN5 may have a physiological role in spinal cord
injury. Strategies aimed at multiple calpain isoforms may offer critical protection
following spinal cord and brain injury.
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Appendix I
Effects of NIM811 on Motor recovery in the Mouse Model of Spinal Cord
Injury

Introduction
A prominent mechanism of secondary tissue degradation is an increase in
mitochondrial permeability to any molecules < 1500 Daltons (Hunter et al. 1976;
Al-Nasser et al. 1986). This increase in mitochondrial permeability can lead to
massive swelling and disruption of the mitochondrial membrane, uncoupling of
oxidative phosphorylation in the electron transport chain and subsequent down
regulation of ATP production (Hunter et al. 1976; Bernardi et al. 1996; Crompton
1999; Halestrap et al. 2002).
Ultimately, it is the formation of the mitochondrial permeability transitional
pore (mPTP) that permits excessive ion permeability and disruption of
mitochondrial bioenergetics (Hunter et al. 1976; Al-Nasser et al. 1986). A critical
finding by Crompton and colleagues was the inhibition of Ca2+ dependent mPTP
opening by the immunosuppressive drug cyclosporine A (CsA)(1988). CsA
mediates its actions by binding to and inhibiting the mitochondrial matrix
component cyclophilin D(CypD) from binding to ANT (Crompton et al. 1998).
CsA inhibited pore formation and subsequent mitochondrial permeability,
prompting the hypothesis that CypD is the regulating component in mPTP
formation.
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CypD has since shown promise as a viable target for protection in rodent
models of TBI (Sullivan et al. 2000; Mbye et al. 2008). However, in rodent
models of SCI, CsA failed to offer any protection unless administered at highly
toxic doses (Rabchevsky et al. 2001; Morota et al. 2007). Recently, a CsA
analog called NIM811 did show some modest protection at the cellular level and
in functional outcome in rat models of SCI (McEwen et al. 2007; Ravikumar et al.
2007). These contradictory results raise uncertainty about the role of CypD in
SCI pathology.
We recently showed that mice with a homozygous knockout of Ppif, the
CypD encoding gene, had no improvements in functional or pathological
outcomes following SCI. These findings suggest that CypD has only a minor role
in secondary spinal cord injury. Thus, the protective effects from NIM811
following SCI may stem from additional protein interactions that induce mPTP
formation independent of CypD.
It is also feasible that there are additional variations in secondary injury
response, including mPTP formation and function, between the mouse and rat
model of SCI. Thus, a comparison between models is critical for translation of
protective strategies across models. In this study, we administered NIM811 to
wild type (WT) mice following a moderate spinal contusion. We then utilized the
Basso mouse scale to assess any improvements in motor function recovery.
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Methods
Animals. All animals were housed in the Division of Laboratory Animal
Resources sector of the University of Kentucky Medical Center, which is fully
accredited by AAALAC. All experimental procedures abide by protocols approved
by the University of Kentucky's Institutional Animal Care and Use Committee.
These studies were performed using B6129 female mice purchased from
Taconic.
Mouse Model of Traumatic Spinal Cord Injury. All experimental procedures were
conducted in accordance with the guidelines of the Institutional Animal Care and
Use Committee (IACUC) of the University of Kentucky. The spinal contusions
administered in these studies were conducted using the commercially available
Infinite Horizon (IH) spinal cord injury device (Precision Systems &
Instrumentation (PSI), Lexington, KY). The IH impactor allows for user defined
parameters to achieve the desired severity of injury. There are three parameters
measured by the IH impactor and defined as follows: Force as the actual force
delivered by the impactor compared to the calibrated force, 2. Velocity as the
speed of the impactor tip as it delivers the contusion, and 3. Displacement as the
elasticity of the spinal cord required until the calibrated force is achieved. The
force of the contusion, measured in kilodyns, was calibrated according to each
severity. For the severe contusions, a calibrated force of 70kdyn was used.
These settings were derived from a previous study characterizing injury gradients
in the mouse model (Basso et al. 2006). Mice were anesthetized by an
intraperitoneal injection ketamine(mg/kg) and xylamine(mg/kg). Laminectomies
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were made to expose the T10 vertebral segment. Two clamps were applied
approximately at the caudal T11 segment and the rostral T9 segment. The spinal
cord was then lowered and straightened until parallel with the platform. Sham
animals received a laminectomy only. Following surgery, all animals were placed
on a heating pad set at 37°C until consciousness and mobility (upper limbs) was
regained. Postoperative care included the manual expression of bladders twice
daily until recovery of bladder function, injection with 10 ml sterile saline
administered subcutaneously (s.c.) immediately after surgery, 33.3 mg/kg
cefazolin, administered by intramuscular injection, twice a day for 1 week then
once a day for the remaining 3 weeks.
Experimental Group and Design. NIM811was generously provided by Dr. Patrick
Sullivan from the University of Kentucky. NIM811 (10mg/kg) was made in a
solution of polyethylene glycol/ .9% sterile saline/cremaphor oil. The vehicle for
NIM811 was the polyethylene glycol/sterile saline/cremaphor oil solution only.
Either NIM811 or vehicle was administered by an intraperitoneally injection at 15
minutes post surgery/injury and another injection 24 hours post surgery/injury.
These experiments involved four groups of mice. Shams with NIM811 2 received
a laminecotmy and NIM811. Shams with vehicle received a laminectomy and
equal volumes of the vehicle. Injured with NIM811 received a moderate spinal
contusion and NIM811, and injured with vehicle received a moderate spinal
contusion and equal volumes of the vehicle. The dose of NIM811 was selected
based on a previous study showing the e optimal doses for attenuating
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mitochondrial dysfunction in mice subjected to cortical contusion (Mbye et al.
2008).
Hind Limb Motor Function Assessment. Motor function following spinal cord
injury was measured by two raters blinded to the experimental conditions. Hind
limb motor function was measured using the Basso Mouse Scale (BMS), a 9
point categorical scale that rates seven observable motor functions and motor
deficits. The seven categories in the BMS included ankle extension, of hind limb
joint movements, trunk stability, stepping coordination, paw placement, and tail
position (Basso et al. 2006). A single score was recorded for the left and right
hind limb which was then averaged to give a total score. An 11 point subscore
was obtained to assess subtle variations within each category. Each BMS test
was assessed by two examiners. One examiner is the main observer while the
other examiner observes and records the scores during the exam. This is to
ensure that one person is observing the test for the entire duration. Each trial is
4 minutes.
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Results
The Basso Mouse Scale (BMS) analysis was used to assess open field
motor function in WT mice following moderate spinal contusion. Mice were
administered either NIM811 or vehicle at 15 minutes and 24 hours post injury.
Immediately following spinal impact, both animals displayed complete bilateral
hind limb paralysis as evident by ankle extension or only ankle extension plus
plantar placement without weight support (data not shown).
Figure10A shows that following moderate SCI, mice administered NIM811
had significantly greater improvement in functional motor recovery at the 2rd week
post injury compared to mice administered vehicle only [F=54.28(391.6,162);
p<.01]. BMS subscores revealed additional time points of increased motor
recovery (Figure 10B). Mice administered NIM811 showed significant
improvements in functional motor recovery at both the 2nd and 3rd week post
injury (Figure 10B)[F=58.51(372,173.8), p<.01 at 2wk, p<.05 at 3wk]. The
improved motor recovery at these time points is most likely due to paw
positioning upon stepping and landing. Mice receiving NIM811 maintained
parallel paw positioning throughout the entire step. This motor skill was not
observed in mice receiving a vehicle until the 4th week.

97

A

BMS Scores For NIM811 Treated
WT Mice
12

NIM811 Sham
Vehicle Sham
NIM811 Injury
Vehicle Injury

BMS Scale Rating

10

**

8
6
4
2
0
3d

1w

2w

3w

4w

Time Post Injury

B

BMS Subscores for NIM811 Treated
WT Mice

BMS Scale Rating

12
10

**

*

2w

3w

NIM811 Sham
Vehicle Sham
NIM811 Injury
Vehicle Injury

8
6
4
2
0
3d

1w

4w

Tim e Post Injury

Figure 10 Basso Mouse Scale(BMS) scores and subscores for WT vehicle and
NIM811 sham and injured mice at 3d, 1wk, 2wk, 3wk, and 4wk post moderate
injury. A. Mice receiving NIM811 showed significant improvement in BMS scores
at 2 weeks following moderate SCI [**p<.01, F=54.28(391.6,162)]. B. Mice
receiving NIM811 showed significant improvement in BMS subscores at 2 weeks
and 3 weeks following moderate SCI [**p<.01 at 2 weeks; *p<.05 at 3 weeks,
F=58.51(372,173.8)]. Values = Mean +/- STDEV. Two-way ANOVA and
Bonferroni post hoc test. N=4-5 for injury and sham groups.
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Discussion and Conclusion
The principle finding in this preliminary study was that NIM811
administered to WT mice following moderate SCI significantly improves motor
function. The purpose of this study was to assess the protective effects of
NIM811 in a mouse model of SCI. Previous studies have produced confounding
results when administering CypD inhibitors in rat models of SCI (Rabchevsky et
al. 2001)
Although NIM811-treated mice showed improvements in motor recovery at
two weeks and three weeks following moderate spinal contusion, the
improvements observed were very modest. Further assessment of tissue
sparing and cellular alterations is needed to further characterize the protective
mechanism of NIM811. Still, these preliminary data provide a critical finding in
that NIM811 has protective effects in mice and rats. This may allow for more
confident translation and interpretation of results across both mouse and rat
models of SCI.
There is still uncertainty if CypD is exclusively targeted by NIM811, at
least in the mouse model. Previously we showed that CypD null mice had no
greater improvements in functional or pathological outcomes following SCI.
Future studies are needed to examine the effects of NIM811 in CypD-null mice.
If NIM811 does improve spinal cord injury outcome in CypD-null mice, this would
suggest that NIM811 targets additional proteins involved in secondary spinal cord
other than CypD.
Copyright©Jordan Clark 2009
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Appendix II
Role of Calpain 5 in Spinal Cord Injury

Introduction
Calpains are Ca2+ dependent cysteine proteases involved in several
cellular functions including cell motility, synaptic remodeling, embryonic
development and (Luscher et al. 2000; Liu et al. 2008). To date, approximately
14 mammalian calpain isoforms have been identified (Goll et al. 2003). Typical
calpain isoforms, µ-calpain and m-calpain, are ubiquitously expressed while
atypical isoforms are tissue specific (Goll et al. 2003). Typical mammalian
calpains generally consist of a large distinctive catalytic subunit and a small
common regulatory subunit (Goll et al. 2003). Several proteins are substrates for
calpain such as cytoskeletal structural and cell motility proteins (Posmantur et al.
1994; Pang et al. 1996; Azam et al. 2001).
Hyper activation of calpain has been implemented in pathological events,
specifically secondary cellular degradation following traumatic brain injury (TBI)
and spinal cord injury (SCI) (Banik et al. 1982; Saido et al. 1994; Huang et al.
2001).(Huang et al. 2001) Several studies have shown that pharmacological
inhibition of calpain attenuates motor deficits and tissue degradation in rodent
models of TBI and SCI (Springer et al. 1997; Ray et al. 1999; Schumacher et al.
2000; Deng et al. 2007). Thus, there has been an extensive effort to identify
additional calpains potentially involved in the pathology of TBI and SCI.
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Previously, calpain-5 (CAPN5) was cloned and characterized in rats and
found to have a highly homologous sequence to both human and mice (Matena
et al. 1998; Waghray et al. 2004). In rats and humans, CAPN5 was shown to be
ubiquitously expressed in several brain regions including the medulla oblongata,
hypothalamus, thalamus, cerebellum, and frontal lobe (Waghray et al. 2004). In
addition, CAPN5 was shown to have key calcium binding domains similar to the
typical calcium dependent calpains. These characteristics suggest that CAPN5
may be involved in neurological injury. To assess the potential involvement of
CAPN5 in SCI, we administered a severe spinal contusion to CAPN5-/+ mice.
Our results suggest that CAPN5 may be a key calpain isoform that exacerbates
functional outcome in spinal injury.
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Methods
Animals. All animals were housed in the Division of Laboratory Animal
Resources sector of the University of Kentucky Medical Center, which is fully
accredited by AAALAC. All experimental procedures abide by protocols approved
by the University of Kentucky's Institutional Animal Care and Use Committee.
Mice with a heterozygous knockout of CAPN5 (Capn5tm1Dgen) were purchased
from the Jackson laboratory. The WT mice utilized were B6129 purchased from
Taconic.
Mouse Model of Traumatic Spinal Cord Injury. All experimental procedures were
conducted in accordance with the guidelines of the Institutional Animal Care and
Use Committee (IACUC) of the University of Kentucky. The spinal contusions
administered in these studies were conducted using the commercially available
Infinite Horizon (IH) spinal cord injury device (Precision Systems &
Instrumentation (PSI), Lexington, KY). The IH impactor allows for user defined
parameters to achieve the desired severity of injury. There are three parameters
measured by the IH impactor and defined as follows: Force as the actual force
delivered by the impactor compared to the calibrated force, 2. Velocity as the
speed of the impactor tip as it delivers the contusion, and 3. Displacement as the
elasticity of the spinal cord required until the calibrated force is achieved. The
force of the contusion, measured in kilodyns, was calibrated according to each
severity. For the severe contusions, a calibrated force of 70kdyn was used.
These settings were derived from a previous study characterizing injury gradients
in the mouse model (Basso et al. 2006). Mice were anesthetized by an
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intraperitoneal injection ketamine(mg/kg) and xylamine(mg/kg). Laminectomies
were made to expose the T10 vertebral segment. Two clamps were applied
approximately at the caudal T11 segment and the rostral T9 segment. The spinal
cord was then lowered and straightened until parallel with the platform. Sham
animals received a laminectomy only. Following surgery, all animals were placed
on a heating pad set at 37°C until consciousness and mobility (upper limbs) was
regained. Postoperative care included the manual expression of bladders twice
daily until recovery of bladder function, injection with 10 ml sterile saline
administered subcutaneously (s.c.) immediately after surgery, 33.3 mg/kg
cefazolin, administered by intramuscular injection, twice a day for 1 week then
once a day for the remaining 3 weeks.
Hind Limb Motor Function Assessment. Motor function following spinal cord
injury was measured by two raters blinded to the experimental conditions. Hind
limb motor function was measured using the Basso Mouse Scale (BMS), a 9
point categorical scale that rates seven observable motor functions and motor
deficits. The seven categories in the BMS included ankle extension, of hind limb
joint movements, trunk stability, stepping coordination, paw placement, and tail
position (Basso et al. 2006). A single score was recorded for the left and right
hind limb which was then averaged to give a total score. An 11 point subscore
was obtained to assess subtle variations within each category. Each BMS test
was assessed by two examiners. One examiner is the main observer while the
other examiner observes and records the scores during the exam. This is to
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ensure that one person is observing the test for the entire duration. Each trial is
4 minutes.
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Results
The Basso Mouse Scale (BMS) analysis was used to assess CAPN5+/and WT mice for open field motor function following severe spinal contusion.
Immediately following spinal impact, both animals displayed complete bilateral
hind limb paralysis as evident by ankle extension or only ankle extension plus
plantar placement without weight support (data not shown).
Figure 11A. and B show that following severe SCI, CAPN5+/- mice had a
significantly greater improvement in functional motor recovery at the 2rd week
post injury [F=17.28(337.2,48.65); p<.01]. CAPN5+/- mice showed recovery of
some coordination, occasional to consistent stepping, and only mild trunk
stability. While WT did eventually achieve the same level of motor recovery, this
wasn’t observed until the 3rd and 4th week, as shown by BMS subscores (Figure
9B)[F=7.861(256.2,18.03), p<.001].
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Figure 11 Basso Mouse Scale(BMS) scores and subscores for WT and CAP5+/sham and injured mice at 3d, 1wk, 2wk, 3wk, and 4wk post severe injury. A-B.
CAP5+/-l injured mice showed significant improvement in BMS scores and
subscores compared to WT injured mice at 2 weeks following severe SCI.
Values=Mean +/- STDEV. **p<.01, F=17.28(337.2,48.65); ***p<.001,
F=7.861(256.2,18.03). Two-way ANOVA and Bonferroni post hoc test. N=4-5 for
injury and sham groups.
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Discussion
The results from this study show that CAPN5-/+ mice have improved
functional motor recovery following severe spinal cord contusion. Little is known
about the physiological function of CAPN5-/+ in mice. However, calpains have
been implicated in the pathology of spinal cord injury (Banik et al. 1982; Banik et
al. 1998; Ray et al. 1999). Following spinal contusion, calpain can remain
elevated for days and weeks. Hyper activation of Calpain degrades several
cellular proteins leading to both necrotic and apoptotic mechanisms of death
(Ray et al. 1999). Substantial evidence has shown calpain to be a promising
target for neurological protection following SCI. Previous studies using calpain
inhibitors of calpain demonstrated decreased cellular protein degradation,
increased tissue sparing and improved motor function in rat models of SCI
(Springer et al. 1997; Zhang et al. 2003; Yu et al. 2007).
Here we show that CAPN-5 may also have a role in spinal cord pathology.
Motor recovery was improved in CAPN5-/+ mice at the second week following
severe spinal cord injury. WT mice at this time point had regained only
occasional stepping with some weight support. CAPN5-/+ , however, showed
frequent stepping with full weight support, followed by recovery of some
coordination. Both models achieved the same level of recovery by the 4thweek.
These motor skills included consistent weight bearing and stepping, coordination,
and mild trunk stability. Though, CAPN5-/+ mice recovered these motor skills at
an earlier time point, it did not continue to display improved function.
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Recently, CAPN5 was shown to be ubiquitously expressed in the rat brain
and spinal cord (Waghray et al. 2004). Further characterization showed CAPN5
contained key Ca2+ binding domains (Wagner et al. 1999). These properties of
CAPN5 may reveal a protease function similar toµand m-calpain. This recent
characterization and localization of CAPN5, along with our findings of motor
improvements in CAPN5-/+ mice, suggest that CAPN5 may have a critical role in
spinal cord pathology. It is important to note that we utilized mice with a
heterozygous knockout of CAPN5. This is because homozygous knockouts are
embryonic lethal. Despite only partial ablation of CAPN5, we still observed
functional improvements. Thus, multiple strategies using potent CAPN5-specifc
inhibitors in conjunction with other calpain inhibitors may greatly improve
functional and pathological recovery in spinal injury.

Copyright©Jordan Clark 2009
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Appendix III
Glossary of Important Terms
AIF
AMPA

ANT
ATP
BMS
CsA
CypD
CypD-null
MAP-2

mPT

apoptosis inducing
factor
α-amino-3-hydroxy-5methyl-4isoxazolepropionic acid
adenine nucleotide
translocase
adenosine triphos
-phate
Basso Mouse Scale
cyclosporine A
cyclophilin D
cylophilin D
homozygous knockout
microtubule-associated
protein

mPTP

NMDA
PPIase
ROS
SBP
SCI
TBI
VDAC
WT

mitochondrial
permeability
mitochondrial
permeability transitional
pore
N-Methyl-D-aspartate
peptidyl-prolyl-cis-transisomerase
reactive oxygen species
spectrin breakdown
product
spinal cord injury
traumatic brain injury
voltage dependent
anionic channel
wild type
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